GLP-1 Market
LLY $1152.70 ▲ +0.0% NVO $43.24 ▲ +0.1% PFE $27.61 ▼ -0.1% VKTX $28.99 ▼ -1.3% KLRA $12.83 ▼ -0.7% GPCR $35.00 ▼ -0.3% RHHBY $54.04 ▼ -1.1%
Market data delayed up to 20 min · Source: Twelve Data
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Losartan Potassium

Company
Martin Blomberg Jensen
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
31 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

31 recruiting studies currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Sep 19, 2026

Find a Clinical Trial Near Me

See recruiting studies for Losartan Potassium and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT00162474

    Determinants of Warfarin Metabolism

    Not yet reported Hadassah Medical Organization 1000 participants Est. completion 2030-12 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Recruiting NCT NCT02560805

    Role of Sympathetic Overactivity and Angiotensin II in PTSD and CV

    Not yet reported Emory University 134 participants Est. completion 2027-03-30 1 site Stand-alone
    Other conditions: Stress Disorders, Post-Traumatic
    View official trial listing →
  • Recruiting NCT NCT02735707

    Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia

    Not yet reported UMC Utrecht 20000 participants Est. completion 2028-02 408 sites
    Other conditions: Community-acquired Pneumonia, Influenza, COVID-19
    View official trial listing →
  • Recruiting NCT NCT02817360

    NT-proBNP Selected Prevention of Cardiac Events in Diabetic Patients

    Not yet reported Martin Huelsmann 2400 participants Est. completion 2026-12 21 sites
    Type 2 diabetes Other conditions: Heart Diseases
    View official trial listing →
  • Recruiting NCT NCT03519893

    Bariatric Surgery and Pharmacokinetics of Losartan

    Norwegian University of Science and Technology 12 participants Est. completion 2026-10 1 site
    Other conditions: Obesity, Morbid
    View official trial listing →
  • Recruiting NCT NCT03900793

    Losartan + Sunitinib in Treatment of Osteosarcoma

    Not yet reported University of Colorado, Denver 41 participants Est. completion 2029-08-01 4 sites Stand-alone
    Obstructive sleep apnea
    View official trial listing →
  • Recruiting NCT NCT04191681

    Safety and Efficacy of ARNI After LVAD ImplanT (SEAL-IT) Study

    Not yet reported The Cleveland Clinic 50 participants Est. completion 2022-12 1 site
    Heart failure
    View official trial listing →
  • Recruiting NCT NCT04662723

    Multicentre Clinical Study to Evaluate the Effect of Personalized Therapy on Patients With Immunoglobulin A Nephropathy.

    Not yet reported Fondazione Schena 878 participants Est. completion 2028-12-31 2 sites
    Other conditions: Glomerulonephritis, Immunoglobulin A Nephropathy
    View official trial listing →
  • Recruiting NCT NCT04715568

    Secondhand Tobacco Smoke and Cardiovascular Disease

    Not yet reported University of California, San Francisco 100 participants Est. completion 2026-12-31 1 site Stand-alone
    Cardiovascular disease Other conditions: Hypertension
    View official trial listing →
  • Recruiting NCT NCT05498675

    Effect of Sacubitril/Valsartan on Cardiac Function in Hypertensive Patients Stratified by BMI: A Real World Study

    Beijing Friendship Hospital 180 participants Est. completion 2027-06-30 1 site
    Other conditions: Sacubitril/Valsartan, Hypertension, Obesity
    View official trial listing →
  • Recruiting NCT NCT06108063

    Mitigation of Arthrofibrosis After Total Knee Arthroplasty Using Losartan

    Not yet reported, Not yet reported Steadman Philippon Research Institute 120 participants Est. completion 2027-06-30 1 site Stand-alone
    Other conditions: Knee Arthroplasty, Total
    View official trial listing →
  • Recruiting NCT NCT06143566

    Polypill for Prevention of Cardiomyopathy

    Not yet reported, Not yet reported University of Texas Southwestern Medical Center 200 participants Est. completion 2027-12-01 1 site Stand-alone
    Type 2 diabetes Other conditions: High Blood Pressure
    View official trial listing →
  • Recruiting NCT NCT06150560

    A Study of Angiotensin-II Receptor Blocker on Cardiovascular Remodeling (VALUE Trial)

    Not yet reported Mayo Clinic 120 participants Est. completion 2028-06-01 1 site Stand-alone
    Other conditions: Coarctation of Aorta, High Blood Pressure
    View official trial listing →
  • Recruiting NCT NCT06211335

    Losartan, Pembrolizumab and Stereotactic Body Radiation Therapy for the Treatment of Patients With Locally Recurrent, Refractory or Oligometastatic Head and Neck Squamous Cell Carcinoma

    Not yet reported University of California, Davis 24 participants Est. completion 2027-06 2 sites Stand-alone
    Other conditions: Locally Recurrent Head and Neck Squamous Cell Carcinoma, Metastatic Head and Neck Squamous Cell Carcinoma, Refractory Head and Neck Squamous Cell Carcinoma
    View official trial listing →
  • Recruiting NCT NCT06364176

    Targeting Inflammation With Losartan to Improve Response to Modulator Therapy in Cystic Fibrosis.

    Not yet reported University of Kansas Medical Center 42 participants Est. completion 2027-10 1 site Stand-alone
    Other conditions: Cystic Fibrosis
    View official trial listing →
  • Recruiting NCT NCT06495710

    Arterial Stiffness and Blood Pressure

    Not yet reported VA Office of Research and Development 228 participants Est. completion 2028-12-31 3 sites Stand-alone
    Other conditions: Hypertension, Vascular Stiffness, Aging
    View official trial listing →
  • Recruiting NCT NCT06624904

    Losartan and Social Processing

    Not yet reported University of Oxford 68 participants Est. completion 2025-10-01 1 site Stand-alone
    Other conditions: Social Cognition
    View official trial listing →
  • Recruiting NCT NCT06628154

    Losartan and Emotional Learning

    Not yet reported University of Oxford 60 participants Est. completion 2025-07 1 site Stand-alone
    Other conditions: Emotional Processing
    View official trial listing →
  • Recruiting NCT NCT06636812

    Losartan and Emotional Processing in Young People

    Not yet reported University of Oxford 60 participants Est. completion 2025-12-31 1 site Stand-alone
    Other conditions: Emotional Processing
    View official trial listing →
  • Recruiting NCT NCT06693960

    Evaluating the Pharmacokinetics of Oregano and Potential Oregano-drug Interactions Using a Drug Cocktail Approach

    Not yet reported Washington State University 16 participants Est. completion 2027-01-31 1 site Stand-alone
    Other conditions: Interaction
    View official trial listing →
  • Recruiting NCT NCT06933706

    Losartan to Improve Outcomes After Multi-ligament Knee Injury

    Not yet reported Brigham and Women's Hospital 90 participants Est. completion 2029-09-30 3 sites Stand-alone
    Other conditions: Multi-ligament Knee Injury
    View official trial listing →
  • Recruiting NCT NCT07017023

    Combined Blood Pressure Medication and Activity Scheduling for Low Mood

    Not yet reported University of Oxford 76 participants Est. completion 2026-12-31 1 site Stand-alone
    Other conditions: Emotional Processing, Mood
    View official trial listing →
  • Recruiting NCT NCT07099859

    Effect of Losartan on the Neurohumoral Axis and Ventricular Remodeling of Patients With Severe Aortic Regurgitation Undergoing Valve Surgery.

    Not yet reported Vitor Emer Egypto Rosa 60 participants Est. completion 2029-07-01 1 site Stand-alone
    Heart failure Other conditions: Heart Valve Diseases, Left Ventricle Remodeling, Aortic Regurgitation Disease, Natriuretic Peptide, Brain
    View official trial listing →
  • Recruiting NCT NCT07300670

    The Effect of Losartan on Cephalexin

    Not yet reported Aleksi Tornio 12 participants Est. completion 2026-05-08 1 site
    Obstructive sleep apnea Other conditions: Healthy
    View official trial listing →
  • Recruiting NCT NCT07449000

    Losartan for Corneal Fibrosis

    Not yet reported Universidad Autonoma de Nuevo Leon 46 participants Est. completion 2027-03-01 1 site
    Other conditions: Corneal Scarring Fibrosis
    View official trial listing →
  • Recruiting NCT NCT07513350

    Investigation of the Effectiveness of Exercise and Anti-Fibrotic Approaches in Frozen Shoulder

    Not yet reported Istanbul University 33 participants Est. completion 2027-01 1 site Stand-alone
    Other conditions: Adhesive Capsulitis of Shoulder
    View official trial listing →
  • Recruiting NCT NCT07513883

    The Assessment of Partial Guideline-Directed Medical Therapy Down Titration in Heart Failure in Remission.

    Not yet reported Ziekenhuis Oost-Limburg 100 participants Est. completion 2028-12 1 site Stand-alone
    Heart failure
    View official trial listing →
  • Recruiting NCT NCT07569640

    HFrEF Polypill in Sri Lanka RCT

    Not yet reported Washington University School of Medicine 1672 participants Est. completion 2029-04 11 sites Stand-alone
    Heart failure
    View official trial listing →
  • Recruiting NCT NCT07683585

    Comparative Effectiveness of Dual Antihypertensive Regimens in Patients After Percutaneous Coronary Intervention

    Not yet reported National Medical Research Center for Therapy and Preventive Medicine 207 participants Est. completion 2026-09 1 site
    Other conditions: Hypertension, Coronary Arterial Disease, Percutaneous Coronary Intervention
    View official trial listing →
  • Recruiting NCT NCT07704658

    Pralsetinib DDI Study in Patients With Advanced or Metastatic Solid Tumors

    Not yet reported Rigel Pharmaceuticals 12 participants Est. completion 2027-08-30 2 sites Stand-alone
    Other conditions: NSCLC (Non-small Cell Lung Cancer), Thyroid Cancer, Solid Tumor Malignancies, Advanced Malignancies
    View official trial listing →
  • Recruiting NCT NCT07784296

    Effectiveness and Safety of Sequential Triple Combination Therapy (Amlodipine/Losartan/Chlorthalidone) in Korean Patients With Hypertension

    Hanmi Pharmaceutical Company Limited 3500 participants Est. completion 2028-08-31 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00001534

    Long Term Effects of Enalapril and Losartan on Genetic Heart Disease

    National Heart, Lung, and Blood Institute (NHLBI) 112 participants Est. completion 2003-04 1 site
    Other conditions: Hypertrophic Cardiomyopathy, Left Ventricular Hypertrophy, Myocardial Ischemia
    View official trial listing →
  • Completed NCT NCT00001741

    Study of Inherited Changes of Receptors Located on Blood Vessels

    Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 200 participants Est. completion 2003-04 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT00067990

    Angiotensin II Blockade for Chronic Allograft Nephropathy

    Not yet reported University of Minnesota 153 participants Est. completion 2011-06 2 sites Stand-alone
    Other conditions: Kidney Disease, Proteinuria
    View official trial listing →
  • Completed NCT NCT00090259

    Study to Evaluate Potential Decrease in Hospitalization Events, Time Between Events, and Increasing Longevity in Patients With Symptomatic Heart Failure (0954-948)

    Not yet reported Organon and Co 3834 participants Est. completion 2009-05-13 Stand-alone
    Heart failure
    View official trial listing →
  • Completed NCT NCT00092209

    Antihypertensive Efficacy and Safety of Approved Drugs in Japanese Patients With Essential Hypertension (Banyu Study)(0954A-302)

    Not yet reported Organon and Co 840 participants Est. completion 2002-11
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00097955

    Safety and Efficacy of Aliskiren When Added to Standardized Losartan and Optimal Antihypertensive Therapy in Patients With Hypertension, Type 2 Diabetes and Proteinuria

    Not yet reported Novartis Pharmaceuticals 496 participants Est. completion 2007-04 12 sites
    Chronic kidney disease
    View official trial listing →
  • Terminated NCT NCT00130312

    Effect of Sulodexide in Overt Diabetic Nephropathy

    Not yet reported Keryx Biopharmaceuticals 968 participants Est. completion 2008-03 3 sites Stand-alone
    Chronic kidney disease
    View official trial listing →
  • Completed NCT NCT00133185

    A Randomized, Double-blind, Parallel-group Assessment of the Safety and Efficacy of Telmisartan 40mg Plus Hydrochlorothiazide 12.5mg (Micardis Plus) in Comparison With Losartan 50mg Plus Hydrochlorothiazide 12.5mg in Taiwanese Patients With Mild to Moderate Hypertension

    Not yet reported Boehringer Ingelheim 31 participants Est. completion 2005-03 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00140907

    ALLOGRAFT, A Study to Evaluate the Renal Protective Effects of Losartan (0954-222)(COMPLETED)

    Not yet reported Organon and Co 367 participants Est. completion 2005-01-01
    Other conditions: High Blood Pressure
    View official trial listing →
  • Completed NCT NCT00140959

    Losartan and HCTZ and Amlodipine vs Atenolol and Amlodipine (0954A-309)(COMPLETED)

    Not yet reported Organon and Co 120 participants Est. completion 2004-06-30
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00140985

    Antiproteinuric Efficacy of Losartan Potassium in Patients With Non-Diabetic Proteinuric Renal Diseases (0954-213)

    Not yet reported Organon and Co 97 participants Est. completion 2002-01
    Other conditions: Renal Disorder
    View official trial listing →
  • Completed NCT NCT00143949

    Renin Angiotensin System Study (RASS/B-RASS)

    Not yet reported Michael Mauer, MD 285 participants Est. completion 2008-05 3 sites
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT00151827

    Olmesartan Medoxomil in Hypertension and Renal Impairment

    Not yet reported Sankyo Pharma Gmbh 393 participants Est. completion 2005-07 1 site Stand-alone
    Other conditions: Essential Hypertension, Renal Impairment
    View official trial listing →
  • Withdrawn NCT NCT00152633

    Effect of Losartan on Retinal Endothelial Function in Patients With Essential Hypertension

    Not yet reported, Not yet reported University of Erlangen-Nürnberg Medical School Est. completion 2006-01 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00155064

    Kallikrein-kinin (KKS) and Renin-angiotensin-aldosterone System (RAAS) in Primary Aldosteronism

    Not yet reported National Taiwan University Hospital 100 participants Est. completion 2005-12 1 site
    Other conditions: Hyperaldosteronism
    View official trial listing →
  • Completed NCT NCT00157963

    Hydrochlorothiazide (+) Losartan Potassium vs. Amlodipine Comparative Study (0954A-314)

    Not yet reported Organon and Co 174 participants Est. completion 2006-02-08
    Other conditions: Essential Hypertension
    View official trial listing →
  • Completed NCT NCT00159692

    Amlodipine Diabetic Hypertension Efficacy Response Trial

    Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 739 participants Est. completion 2005-08
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00160225

    Study to Evaluate the Efficacy and Safety of Daglutril Compared to Placebo on Top of Losartan in Type 2 Diabetics With Overt Nephropathy and Well Controlled Hypertension

    Not yet reported Solvay Pharmaceuticals 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00168857

    A Prospective, Randomised, Double-blind, Double-dummy, Forced-titration, Multicentre, Parallel Group, One Year Treatment Trial to Compare Telmisartan (MICARDIS) 80 mg Versus Losartan (COZAAR) 100 mg, in Hypertensive Type 2 Diabetic Patients With Overt Nephropathy (AMADEO Study)

    Not yet reported Boehringer Ingelheim 860 participants 109 sites
    Other conditions: Hypertension, Diabetic Nephropathies
    View official trial listing →
  • Completed NCT NCT00185094

    A Comparison of the Effect of Olmesartan Medoxomil, Losartan Potassium, and Atenolol on the Ability of Overweight Patients With High Blood Pressure to Respond to Insulin

    Not yet reported Daiichi Sankyo 60 participants Est. completion 2005-07 10 sites
    Metabolic syndrome Other conditions: Hypertension, Insulin Resistance
    View official trial listing →
  • Status unknown NCT NCT00198562

    Hypertension Control Based on Home Blood Pressure

    Not yet reported Ministry of Health, Labour and Welfare, Japan 2600 participants Est. completion 2012-03 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00219141

    Aliskiren in Combination With Losartan Compared to Losartan on the Regression of Left Ventricular Hypertrophy in Overweight Patients With Essential Hypertension

    Not yet reported Novartis Pharmaceuticals 460 participants Est. completion 2007-11 9 sites Stand-alone
    Other conditions: Hypertension, Left Ventricular Hypertrophy, Overweight
    View official trial listing →
  • Completed NCT NCT00223717

    Treatment of Supine Hypertension in Autonomic Failure

    Not yet reported Vanderbilt University 152 participants Est. completion 2017-01 1 site Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00231803

    The Canadian Prevention of Renal and Cardiovascular Endpoints Trial

    Not yet reported Brendan Barrett 474 participants Est. completion 2008-06 5 sites Stand-alone
    Chronic kidney disease
    View official trial listing →
  • Completed NCT NCT00234858

    Tarka vs. Hyzaar in Patients With Metabolic Syndrome (STAR)

    Not yet reported Abbott 280 participants
    Metabolic syndrome Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00237588

    Glucose Optimisation With Angiotensin II Antagonist Losartan (GOAAL)

    Not yet reported Ullevaal University Hospital 25 participants Est. completion 2005-07 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Status unknown NCT NCT00239096

    Prevention of Decompensation in Liver Cirrhosis

    Not yet reported Odense University Hospital 100 participants Est. completion 2011-09 1 site
    Other conditions: Alcoholic Liver Cirrhosis, Ascites
    View official trial listing →
  • Completed NCT NCT00274638

    PROBE Parallel 6-week Treatment Comparing Telmisartan/Hydrochlorothiazide (HCT) (40/12.5 or 80/12.5) With Losartan/HCT (50/12.5) Using Ambulatory Blood Pressure Monitoring (ABPM)

    Not yet reported Boehringer Ingelheim 805 participants 69 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00275639

    The Effects of Angiotensin II Receptor Blockade on Kidney Function and Scarring After Liver Transplant

    Not yet reported Mayo Clinic 62 participants Est. completion 2007-08 1 site
    Other conditions: Liver Transplant Recipients
    View official trial listing →
  • Withdrawn NCT NCT00280215

    Renal Protective Effect of ACEI and ARB in Primary Hyperoxaluria

    Not yet reported Mayo Clinic Est. completion 2011-12
    Other conditions: Hyperoxaluria
    View official trial listing →
  • Completed NCT NCT00284128

    AVE7688 in Patients With Mild to Moderate Blood Pressure

    Not yet reported, Not yet reported Sanofi 1940 participants Est. completion 2008-03 21 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00289887

    Obese Hypertension Study (0954-315)

    Not yet reported Organon and Co 261 participants Est. completion 2007-03 Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00298714

    Effects of Losartan on Hepatic Fibrogenesis in Chronic Hepatitis C

    Not yet reported Hospital Clinic of Barcelona 20 participants Est. completion 2006-01
    Other conditions: Chronic Hepatitis C, Liver Fibrosis
    View official trial listing →
  • Completed NCT NCT00307060

    MK0954A-264 Filter Study (0954A-264)(COMPLETED)

    Not yet reported Organon and Co 274 participants Est. completion 2005-06-02
    Other conditions: Mild to Severe Hypertension
    View official trial listing →
  • Completed NCT NCT00308347

    A Research Study to Evaluate the Renal (Kidney) Protective Effects of Losartan in Patients With Non-insulin Dependent Diabetes (0954-147)(COMPLETED)

    Not yet reported Organon and Co 1513 participants Est. completion 2001-04
    Type 2 diabetes Other conditions: Nephropathy
    View official trial listing →
  • Completed NCT NCT00325637

    Cilnidipine Effect on High Blood Pressure and Cerebral Perfusion in Ischemic Stroke Patients With Hypertension

    Not yet reported Boryung Pharmaceutical Co., Ltd 250 participants Est. completion 2007-08 1 site
    Cardiovascular disease Other conditions: Hypertension
    View official trial listing →
  • Terminated NCT NCT00338091

    Long-Term Renoprotection of Optimal Antiproteinuric Doses of Benazepril and Losartan in Chronic Renal Insufficiency

    Not yet reported Southern Medical University, China Est. completion 2006-05 1 site
    Other conditions: Renal Insufficiency,Chronic, Disease Progression, Proteinuria, Dose-Response Relationship,Drug, ACE Inhibitor, Angiotensin II Type 1 Receptor Blockers
    View official trial listing →
  • Completed NCT NCT00338260

    Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study (0954-133)

    Not yet reported Organon and Co 496 participants Est. completion 2001-11
    Other conditions: Hypertension and Left Ventricular Hypertrophy (Thickening of the Main Pumping Chamber of the Heart)
    View official trial listing →
  • Completed NCT NCT00340678

    Renoprotection in Early Diabetic Nephropathy in Pima Indians

    Not yet reported National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 170 participants Est. completion 2014-03 1 site Stand-alone
    Chronic kidney disease
    View official trial listing →
  • Completed NCT NCT00344110

    Study Comparing SPP100 (Aliskiren) 150mg to Placebo and to Losartan 50mg in Patients With Mild to Moderate Essential Hypertension

    Not yet reported Novartis 768 participants Est. completion 2007-04 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00354991

    Hyzaar Asia HEAALTH (0954A-950)

    Not yet reported Merck Sharp & Dohme LLC 437 participants Est. completion 2007-04-01 Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00361023

    Effects of Losartan on Insulin Sensitivity and Secretion in Type 2 Diabetes and Nephropathy

    Not yet reported Shanghai Jiao Tong University School of Medicine 25 participants Est. completion 2006-07
    Type 2 diabetesChronic kidney disease
    View official trial listing →
  • Completed NCT NCT00362960

    Olmesartan Medoxomil and Diabetic Nephropathy

    Not yet reported Sankyo Pharma Gmbh 300 participants Est. completion 2004-09 27 sites
    Type 2 diabetesChronic kidney disease Other conditions: Proteinuria, Renal Disease
    View official trial listing →
  • Completed NCT NCT00364988

    Pioglitazone and Losartan Provides Additional Renoprotection

    Not yet reported Shanghai Jiao Tong University School of Medicine 60 participants Est. completion 2006-01
    Type 2 diabetesChronic kidney disease
    View official trial listing →
  • Suspended NCT NCT00369538

    Specific Blockage of Angiotensine 2 and Podocyturia in Glomerular Nephropathies With Hypertension and Proteinuria

    Not yet reported University Hospital, Strasbourg, France 20 participants 1 site
    Other conditions: Proteinuria, Hypertension, End Stage Renal Disease
    View official trial listing →
  • Status unknown NCT NCT00378443

    ACEi/ARB Alone Versus ACEi/ARB Plus Steroids in the Treatment of Primary IgA Nephropathy, a RCT

    Not yet reported Peking University Est. completion 2007-06
    Other conditions: Glomerulonephritis, IGA
    View official trial listing →
  • Completed NCT NCT00381134

    Improving Outcomes in Patients With Kidney Disease Due to Diabetes

    Not yet reported National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 92 participants Est. completion 2006-12 1 site
    Other conditions: Diabetes, Kidney Disease, Hypertension
    View official trial listing →
  • Terminated NCT NCT00388388

    Losartan Versus Hydrochlorothiazide in Reversing Remodeling of Small Arteries in Pre-Hypertensive Pre-Diabetic Subjects

    Not yet reported Sir Mortimer B. Davis - Jewish General Hospital 1 participants Est. completion 2009-12 1 site Stand-alone
    Prediabetes Other conditions: Pre-hypertension
    View official trial listing →
  • Completed NCT NCT00398541

    Evaluation of the Antihypertensive Effect of Hyzaar(R) and Cognitive Function of Hypertensive Patients (0954A-322)

    Not yet reported Organon and Co 41 participants Est. completion 2007-06-01
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00400218

    Evaluate the Safety and Anti-Hypertensive Efficacy of Hyzaar(R) In Patients With Mild To Moderate Essential Hypertension (0954A-323)

    Not yet reported Organon and Co 62 participants Est. completion 2006-07-19
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00402194

    Treating the Endothelium to Restore Insulin Sensitivity

    Not yet reported Indiana University 17 participants Est. completion 2012-03 1 site
    Prediabetes Other conditions: Obesity, Insulin Resistance
    View official trial listing →
  • Completed NCT NCT00407862

    Telmisartan and Losartan in Hypertensive IGT

    Not yet reported Medical University of Graz 24 participants Est. completion 2006-06 1 site
    Prediabetes Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00419835

    Effect of Enalapril and Losartan Association Therapy on Proteinuria and Inflammatory Biomarkers in Diabetic Nephropathy: a Clinical Trial on Type 2 Diabetes Mellitus

    Not yet reported University of Sao Paulo 80 participants Est. completion 2007-09 1 site
    Chronic kidney disease
    View official trial listing →
  • Completed NCT NCT00429364

    Comparison of Two Medications Aimed at Slowing Aortic Root Enlargement in Individuals With Marfan Syndrome

    Not yet reported Carelon Research 608 participants Est. completion 2014-02 26 sites
    Other conditions: Marfan Syndrome
    View official trial listing →
  • Completed NCT NCT00446563

    Efficacy and Safety of Valsartan in Combination With Amlodipine Compared to Losartan Plus Hydrochlorothiazide in Patients With Hypertension and Left Ventricular Hypertrophy

    Not yet reported Novartis 90 participants Est. completion 2010-03 1 site
    Other conditions: Hypertension; Hypertrophy, Left Ventricular
    View official trial listing →
  • Completed NCT NCT00446862

    The Fabrazyme® and Arbs and ACE Inhibitor Treatment (FAACET) Study

    University of Alabama at Birmingham 36 participants Est. completion 2012-12 6 sites
    Other conditions: Fabry Disease, Proteinuria
    View official trial listing →
  • Terminated NCT NCT00447603

    A Study of Losartan Compared to Losartan/HCTZ in Pediatric Patients With Hypertension (0954A-327)

    Not yet reported Organon and Co 40 participants Est. completion 2007-10-22 Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Terminated NCT NCT00449111

    An Open Label Study to Assess the Efficacy, Safety and Tolerability of COZAAR Plus (Losartan Potassium 50mg/Hydrochlorothiazide 12.5mg) Possibly Titrated up to COZAAR Plus-F (Losartan Potassium 100mg/Hydrochlorothiazide 25mg) in Patients With Essential Hypertension (0954A-325)

    Not yet reported Organon and Co 11 participants Est. completion 2006-09-30
    Other conditions: Hypertension
    View official trial listing →
  • Terminated NCT NCT00456963

    Prevention of Diabetes and Hypertension

    Not yet reported Istituto Auxologico Italiano 3000 participants Est. completion 2010-03 1 site Stand-alone
    Other conditions: Diabetes Mellitus, Hypertension
    View official trial listing →
  • Terminated NCT NCT00467831

    Pilot Study of a Multi-Drug Regimen for Severe Pulmonary Fibrosis in Hermansky-Pudlak Syndrome

    Not yet reported, Not yet reported National Human Genome Research Institute (NHGRI) 3 participants Est. completion 2012-11 1 site Stand-alone
    Other conditions: Hermansky-Pudlak Syndrome (HPS), Pulmonary Fibrosis, Oculocutaneous Albinism, Platelet Storage Pool Deficiency, Metabolic Disease
    View official trial listing →
  • Completed NCT NCT00480805

    HYZAAR vs. Ramipril for Diabetes (0954A-245)(COMPLETED)

    Not yet reported Organon and Co 312 participants Est. completion 2002-10-16
    Type 2 diabetes Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00492128

    Kanagawa Combination Anti-hypertensive Therapy (K-CAT)

    Not yet reported Yokohama City University Medical Center 196 participants Est. completion 2010-08 1 site Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00496834

    LAAS (Losartan Anti-Atherosclerosis Study)(0954-330)(COMPLETED)

    Not yet reported Organon and Co 201 participants Est. completion 2009-09-01 Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00519870

    Losartan Therapy in Pulmonary Hypertension

    Not yet reported Baskent University Est. completion 2005-07
    Other conditions: Pulmonary Hypertension
    View official trial listing →
  • Completed NCT NCT00530595

    Effects of Angiotensin Receptor Antagonist on Prohibiting Cardiovascular Events on Hemodialysis Patients

    Not yet reported Saitama Medical University
    Cardiovascular disease
    View official trial listing →
  • Status unknown NCT NCT00533858

    Effect of Lacidipine and Losartan on 24 Hour Systolic Blood Pressure Variability in Elderly Hypertensive Patients

    Not yet reported Seoul National University Hospital 160 participants Est. completion 2008-09 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00541684

    Health Assessment Study (0954-946)

    Not yet reported Organon and Co 143 participants Est. completion 2003-01-23
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00546052

    A 52 Week Study to Evaluate the Effects of Losartan With or Without HCTZ on Plasma Glucose, Metabolic Parameters, Blood Pressure in Hypertensive Patients With Metabolic Syndrome (0954A-331)

    Not yet reported Organon and Co 1738 participants Est. completion 2008-01-01 Stand-alone
    Other conditions: Hypertension, Metabolic Disorder
    View official trial listing →
  • Completed NCT NCT00546754

    BP-EASE -Effectiveness of Losartan 50 mg/Hydrochlorothiazide (HCTZ) 12.5 mg Versus Valsartan 80 mg/HCTZ 12.5 mg Titrated as Needed in Patients With Essential Hypertension Not Controlled on Monotherapy (0954A-333)

    Not yet reported Organon and Co 808 participants Est. completion 2009-05-01 Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Terminated NCT NCT00555217

    VA NEPHRON-D: Diabetes iN Nephropathy Study

    Not yet reported US Department of Veterans Affairs 1448 participants Est. completion 2014-10 31 sites Stand-alone
    Type 2 diabetes Other conditions: Kidney Disease, Nephropathy
    View official trial listing →
  • Status unknown NCT NCT00561327

    PPARgamma Activation by Losartan in Hypertensive Patients: The Importance of Losartan-Metabolites

    German Heart Institute 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00561704

    Adiponectin in Obese Women With T2DN and Effects by RAS Blocker

    Not yet reported Shanghai Jiao Tong University School of Medicine 80 participants Est. completion 2007-10
    Type 2 diabetesChronic kidney disease Other conditions: Obese, Glucose Metabolism, Angiotensin II Type 1 Receptor Blockers
    View official trial listing →
  • Status unknown NCT NCT00565396

    Effectiveness Study on Fosinopril and/or Losartan in Patients With Chronic Kidney Disease Stage 3

    Not yet reported Shanghai Municipal Health Bureau 400 participants Est. completion 2008-07 26 sites
    Other conditions: Chronic Kidney Insufficiency, Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Type 1 Receptor Blockers, Proteinuria
    View official trial listing →
  • Completed NCT NCT00568178

    An Extension Study Designed to Assess Effects of Losartan on Proteinuria in Pediatric Populations (MK-0954-326 AM1,EXT1(AM2))

    Not yet reported Organon and Co 306 participants Est. completion 2011-03-01 Stand-alone
    Other conditions: Proteinuria
    View official trial listing →
  • Completed NCT NCT00593710

    Losartan Versus Atenolol for the Treatment of Marfan Syndrome

    Not yet reported University of British Columbia 17 participants Est. completion 2011-12 1 site Stand-alone
    Other conditions: Marfan Syndrome
    View official trial listing →
  • Completed NCT NCT00602004

    Attenuation of Cardiac Effects of Arteriovenous Fistula Creation With Losartan

    Not yet reported Melbourne Health 52 participants Est. completion 2014-12 1 site
    Other conditions: Renal Failure, Left Ventricular Hypertrophy
    View official trial listing →
  • Completed NCT NCT00617877

    Antihypertensive Response to Losartan and Genetic Polymorphisms

    Not yet reported Merck Sharp & Dohme LLC 800 participants Est. completion 2009-06 Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00620178

    Atacand (Candesartan) Real Life Study

    AstraZeneca 14000 participants Est. completion 2009-02 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Terminated NCT NCT00630708

    Safety of Dual Blockage of Rennin-angiotensin System in Patients With Advanced Renal Insufficiency

    Not yet reported Nanfang Hospital, Southern Medical University 309 participants Est. completion 2014-03 1 site
    Other conditions: Renal Insufficiency, Chronic
    View official trial listing →
  • Status unknown NCT NCT00647257

    The Effect of Losartan on Atrial Fibrillation (AF) Burden and Pacemaker Dependence in Patients With Sick Sinus Syndrome

    Not yet reported Chung Shan Medical University 220 participants Est. completion 2009-12 1 site
    Other conditions: Atrial Fibrillation
    View official trial listing →
  • Terminated NCT NCT00649311

    A Study To Evaluate The Efficacy Of Eplerenone Compared With Losartan For The Treatment Of Patients With Mild To Moderate Hypertension

    Not yet reported Pfizer 248 participants Est. completion 2003-09 2 sites
    Other conditions: Hypertension
    View official trial listing →
  • Status unknown NCT NCT00651235

    A Randomized, Open-label, LOSARTAN Therapy on the Progression of Aortic Root Dilation in Patients With Marfan Syndrome

    Not yet reported National Taiwan University Hospital 44 participants Est. completion 2011-06 1 site Stand-alone
    Other conditions: Marfan Syndrome
    View official trial listing →
  • Status unknown NCT NCT00659451

    Effects Of Losartan On Myocardial Structure In Diabetic Hypertensive Patients With Left Ventricular

    Not yet reported University of Pavia 100 participants Est. completion 2009-04 1 site Stand-alone
    Other conditions: Essential Hypertension, Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00663377

    Effects of Losartan on Insulin Resistance in Patients With Heart Failure

    Not yet reported Tottori University Hospital 16 participants Est. completion 2007-03
    Heart failure
    View official trial listing →
  • Status unknown NCT NCT00669435

    Losartan and Simvastatin in Hypertensive Obeses With Liver Steatosis

    Not yet reported University of Pavia 75 participants Est. completion 2009-04 1 site Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00670787

    Combination Pill of Losartan Potassium and Hydrochlorothiazide for Improvement of Medication Compliance Trial

    Not yet reported Kyushu University 207 participants Est. completion 2011-02 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00673790

    The Blood Pressure and Metabolic Effects of Nebivolol in Hypertensive Patients With Impaired Glucose Tolerance or Impaired Fasting Glucose

    Not yet reported Forest Laboratories 537 participants Est. completion 2010-07-09 88 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00675987

    A Randomized Clinical Trial To Study Losartan On Endothelial Dysfunction and Insulin Resistance In Obese Patients

    Not yet reported Brigham and Women's Hospital 53 participants Est. completion 2008-12 9 sites
    Other conditions: Obesity, Hypertension, Hyperglycemia
    View official trial listing →
  • Status unknown NCT NCT00683124

    Nebivolol Versus Losartan Versus Nebivolol+Losartan Against Aortic Root Dilation in Genotyped Marfan Patients

    Not yet reported Fondazione IRCCS Policlinico San Matteo di Pavia 291 participants Est. completion 2013-07 1 site Stand-alone
    Other conditions: Marfan Syndrome
    View official trial listing →
  • Completed NCT NCT00684489

    Renin-Guided Therapeutics in the Management of Untreated, Uncontrolled, or Complicated Hypertension

    Not yet reported Medical University of South Carolina 52 participants Est. completion 2005-09
    Other conditions: Hypertension
    View official trial listing →
  • Status unknown NCT NCT00699036

    Rosiglitazone Versus Rosiglitazone and Metformin Versus Rosiglitazone and Avandia in the Treatment of Nonalcoholic Steatohepatitis (NASH)

    Not yet reported Brooke Army Medical Center 165 participants Est. completion 2009-08 1 site Stand-alone
    MASHMASLD
    View official trial listing →
  • Completed NCT NCT00701428

    Losartan in Hypertensive Men and Women With Sleep Apnea Before and on Continuous Positive Airway Pressure (CPAP) Treatment

    Not yet reported Skaraborg Hospital 90 participants Est. completion 2014-02 1 site Stand-alone
    Other conditions: Hypertension, Sleep Apnea
    View official trial listing →
  • Status unknown NCT NCT00716950

    Valsartan and Amlodipine Compared to Losartan and Amlodipine in Hypertensive Patients

    Not yet reported University of Pavia 187 participants Est. completion 2009-02 1 site
    Other conditions: Essential Hypertension
    View official trial listing →
  • Completed NCT NCT00720226

    Efficacy of Losartan in Preventing Progression of COPD

    Not yet reported Johns Hopkins University 106 participants Est. completion 2016-08 1 site Stand-alone
    Other conditions: COPD, Emphysema, Chronic Bronchitis, Smoking
    View official trial listing →
  • Completed NCT NCT00720577

    Study to Evaluate the Effect of Simvastatin, Losartan and Pioglitazone on Patients With Peripheral Arterial Disease.

    Not yet reported Medtronic Endovascular 164 participants Est. completion 2007-08
    Other conditions: Peripheral Arterial Disease
    View official trial listing →
  • Completed NCT NCT00723801

    Effects of Losartan Versus Atenolol on Aortic and Cardiac Muscle Stiffness in Adults With Marfan Syndrome

    Not yet reported Brigham and Women's Hospital 40 participants Est. completion 2012-12 1 site
    Other conditions: Marfan Syndrome
    View official trial listing →
  • Status unknown NCT NCT00732407

    Aliskiren's Effect on Arterial Stiffness and Platelet Function in Patients With Diabetes Mellitus (DM)

    Not yet reported Assaf-Harofeh Medical Center 40 participants Stand-alone
    Other conditions: Diabetes Mellitus, Atherosclerosis
    View official trial listing →
  • Status unknown NCT NCT00732966

    Ocsaar and CYP2C9 Ploymorphism, Is There a Connection Between Pharmacokinetics, Pharmacodynamics and Pharmacogenetics?

    Not yet reported Assaf-Harofeh Medical Center 30 participants Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00734630

    Efficacy and Safety of Nebivolol (Added to Lisinopril or Losartan) in Hypertensive Patients

    Not yet reported Forest Laboratories 491 participants Est. completion 2010-05 75 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00739674

    SAALT: Subtracting Salt and Adding Losartan Trial (0954A-335)

    Not yet reported Organon and Co 992 participants Est. completion 2010-01-01 Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00751751

    Olmesartan Medoxomil Versus Losartan in Elderly and Very Elderly

    Not yet reported Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company 441 participants Est. completion 2005-06 1 site
    Other conditions: Essential Hypertension
    View official trial listing →
  • Completed NCT NCT00754429

    The Effect of Losartan Versus Amlodipine-based Therapy in Ischemic Stroke (0954-338)(COMPLETED)

    Not yet reported Taipei Veterans General Hospital, Taiwan 40 participants Est. completion 2009-07 Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT00756938

    Study of Losartan in Pediatric Patients With Hypertension (MK-0954-337)

    Not yet reported Organon and Co 101 participants Est. completion 2012-08-14 Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Terminated NCT NCT00763893

    Study of the Efficacy of Losartan on Aortic Dilatation in Patients With Marfan Syndrome

    Not yet reported Assistance Publique - Hôpitaux de Paris 303 participants Est. completion 2014-12 1 site
    Other conditions: Marfan Syndrome
    View official trial listing →
  • Completed NCT NCT00774904

    Adiponectin and Insulin Resistance in Diabetic Nephropathy

    Not yet reported Xi'an Jiaotong University 80 participants Est. completion 2007-11 1 site
    Chronic kidney disease
    View official trial listing →
  • Completed NCT NCT00782327

    Randomized, Double-blind Study for the Evaluation of the Effect of Losartan Versus Placebo on Aortic Root Dilatation in Patients With Marfan Syndrome Under Treatment With Beta-blockers

    Not yet reported University Hospital, Ghent 22 participants Est. completion 2014-11-26 1 site Stand-alone
    Other conditions: Marfan Syndrome
    View official trial listing →
  • Completed NCT NCT00795847

    Morning Hypertension and Preminent Therapy Study

    Not yet reported Kurume University 216 participants Est. completion 2010-11 1 site Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Terminated NCT NCT00805311

    Aggressive Medical Treatment Evaluation for Asymptomatic Carotid Artery Stenosis

    Not yet reported Russian Cardiology Research and Production Center 400 participants Est. completion 2014-05 2 sites Stand-alone
    Cardiovascular disease Other conditions: Carotid Artery Stenosis, Atherosclerosis
    View official trial listing →
  • Status unknown NCT NCT00813722

    Effect of Active Telephone Calls in the Compliance of Hypertensive Patients With Treatment

    Not yet reported University of Sao Paulo 400 participants Est. completion 2009-06 2 sites
    Other conditions: Blood Pressure
    View official trial listing →
  • Completed NCT NCT00814255

    Novel Therapies for Resistant FSGS (FONTII): Phase II Clinical Trial

    Not yet reported NYU Langone Health 32 participants Est. completion 2014-02 18 sites
    Other conditions: Focal Segmental Glomerulosclerosis
    View official trial listing →
  • Completed NCT NCT00856271

    Olmesartan Medoxomil Versus Losartan Potassium in Patients With Mild to Moderate Essential Hypertension

    Not yet reported Daiichi Sankyo 287 participants Est. completion 2005-04 5 sites
    Other conditions: Essential Hypertension
    View official trial listing →
  • Completed NCT NCT00856960

    The Effect of Hypertension Medications on Renal Blood Flow Measurements in Healthy Males (MK-0000-127)

    Not yet reported Merck Sharp & Dohme LLC 12 participants Est. completion 2010-04
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00857285

    Olmesartan Medoxomil Versus Losartan in Patients With Hypertension

    Not yet reported Daiichi Sankyo 130 participants Est. completion 2003-09 3 sites
    Other conditions: Essential Hypertension
    View official trial listing →
  • Completed NCT NCT00879879

    Losartan in Treating Patients With Idiopathic Pulmonary Fibrosis

    Not yet reported University of South Florida 20 participants Est. completion 2012-03 1 site Stand-alone
    Other conditions: Precancerous Condition
    View official trial listing →
  • Withdrawn NCT NCT00880386

    Losartan in Treating Pulmonary Fibrosis in Patients With Stage I, II, or III Non-Small Cell Lung Cancer

    Not yet reported University of South Florida Est. completion 2010-04 Stand-alone
    Other conditions: Dyspnea, Lung Cancer, Pulmonary Complications, Radiation Fibrosis
    View official trial listing →
  • Completed NCT NCT00882440

    A Study to Investigate the Efficacy and Safety of Different Doses of Losartan Potassium (MK0954-011)

    Not yet reported Merck Sharp & Dohme LLC 576 participants Est. completion 1992-01 Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00886600

    A Study to Investigate the Magnitude and Duration of Response of MK0954 Compared to Placebo in Patients With Hypertension (0954-021)(COMPLETED)

    Not yet reported Merck Sharp & Dohme LLC 122 participants Est. completion 1992-08 Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00887250

    A Study to Investigate the Antihypertensive Efficacy of MK0954

    Not yet reported Merck Sharp & Dohme LLC 366 participants Est. completion 1992-11 Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00888355

    MK0954 Versus Placebo for Treatment of Mild to Moderate Hypertension

    Not yet reported Merck Sharp & Dohme LLC 428 participants Est. completion 1993-02 Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00907374

    Low Dose Versus Aggressive Inhibition of the Renin-Angiotensin-Aldosterone (RAS) to Treat Microalbuminuria

    Not yet reported Charles Drew University of Medicine and Science 46 participants Est. completion 2009-04 1 site Stand-alone
    Other conditions: Microalbuminuria
    View official trial listing →
  • Completed NCT NCT00922311

    Aliskiren for Proteinuric IgAN Despite Angiotensin Blockade

    Not yet reported The University of Hong Kong 25 participants Est. completion 2010-12 2 sites
    Other conditions: IgA Nephropathy
    View official trial listing →
  • Completed NCT NCT00922480

    Clinical Study to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan in Hypertension Patients

    Not yet reported Boryung Pharmaceutical Co., Ltd 506 participants Est. completion 2009-09
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00931710

    Valsartan/Amlodipine As Compared to Losartan Treatment in Stage 2 Systolic Hypertension

    Not yet reported Novartis 488 participants Est. completion 2010-01 1 site
    Other conditions: Stage 2 Systolic Hypertension
    View official trial listing →
  • Completed NCT NCT00940667

    Efficacy/Safety of Amlodipine Plus Losartan Versus Amlodipine in Patients With Essential Hypertension

    Not yet reported Hanmi Pharmaceutical Company Limited 185 participants Est. completion 2008-12 1 site Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00940680

    Efficacy/Safety of Amlodipine Plus Losartan Versus Losartan in Patients With Essential Hypertension

    Not yet reported Hanmi Pharmaceutical Company Limited 142 participants Est. completion 2008-11 1 site Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00942344

    Efficacy and Safety of Amlodipine and Losartan in Patients With Essential Hypertension

    Not yet reported Hanmi Pharmaceutical Company Limited 320 participants Est. completion 2007-12 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00943852

    The Effect of Losartan and Losartan Plus Isosorbide Mononitrate on Central Blood Pressure Measurements (0954-317)

    Not yet reported Organon and Co 13 participants Est. completion 2006-12
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00949884

    Olmesartan Comparison to Losartan in Hypertensive Subjects

    Not yet reported Daiichi Sankyo 941 participants Est. completion 2010-01 20 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00953680

    Bioequivalence of Losartan and Hydrochlorothiazide (HCTZ) Combination Tablet and Coadministration of Its Components (0954A-306)

    Not yet reported Organon and Co 77 participants Est. completion 2004-07
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00971165

    Diuretics and Angiotensin-Receptor Blocker Agents in Patients With Stage I Hypertension

    Not yet reported Hospital de Clinicas de Porto Alegre 655 participants Est. completion 2014-09 2 sites Stand-alone
    Cardiovascular disease Other conditions: Hypertension
    View official trial listing →
  • Terminated NCT NCT00981747

    Targeting Vascular Reactivity in Idiopathic Pulmonary Fibrosis

    Not yet reported, Not yet reported Alicia Gerke 12 participants Est. completion 2016-12 1 site Stand-alone
    Other conditions: Idiopathic Pulmonary Fibrosis, Pulmonary Fibrosis
    View official trial listing →
  • Terminated NCT NCT00981929

    Development of Cocktail for Measuring the Activity of Important Cytochrome P450 Enzymes

    Not yet reported University of Southern Denmark 412 participants Est. completion 2011-01 1 site
    Other conditions: Cytochrome P450 Phenotype and Genotype Metrics
    View official trial listing →
  • Status unknown NCT NCT00994617

    Monotherapy Versus Dual Therapy for Initial Treatment for Hypertension

    Not yet reported University of Cambridge 600 participants Est. completion 2014-12 13 sites Stand-alone
    Other conditions: Hypertension, Resistant to Conventional Therapy, Essential Hypertension
    View official trial listing →
  • Completed NCT NCT01011062

    Effect of Angiotensin Receptor Blockade on Insulin Resistance and Adipose Tissue Cytokines in Type 2 Diabetes

    Not yet reported Institute for Clinical and Experimental Medicine 23 participants Est. completion 2009-08 1 site Stand-alone
    Type 2 diabetes Other conditions: Insulin Resistance
    View official trial listing →
  • Completed NCT NCT01015937

    Effect of Turmeric on Diabetic Nephropathy

    Not yet reported Shaheed Faghihi Hospital 50 participants Est. completion 2009-08 1 site
    Chronic kidney disease Other conditions: Proteinuria
    View official trial listing →
  • Completed NCT NCT01033318

    A Study of the Pharmacokinetics and Pharmacodynamics of MK1809 (1809-001)(COMPLETED)

    Not yet reported Merck Sharp & Dohme LLC 30 participants Est. completion 2008-06-19 Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01041807

    Cozaar XQ Re-examination Study (MK-0954-349)

    Organon and Co 669 participants Est. completion 2015-03
    Other conditions: Hypertension
    View official trial listing →
  • Status unknown NCT NCT01041963

    The Effect of Enalapril and Losartan on Peritoneal Membrane in Continuous Ambulatory Peritoneal Dialysis Patients

    Not yet reported Chulalongkorn University 90 participants Est. completion 2010-09 1 site
    Other conditions: Continuous Ambulatory Peritoneal Dialysis
    View official trial listing →
  • Completed NCT NCT01051219

    Anti-Fibrotic Effects of Losartan In Nash Evaluation Study

    Not yet reported Newcastle-upon-Tyne Hospitals NHS Trust 45 participants Est. completion 2014-12 10 sites
    MASH
    View official trial listing →
  • Completed NCT NCT01086722

    Pharmacokinetics in Morbid Obesity After Bariatric Surgery

    Not yet reported, Not yet reported Fundacion IMIM 52 participants Est. completion 2013-03 2 sites Stand-alone
    Other conditions: Morbid Obesity, Overweight
    View official trial listing →
  • Completed NCT NCT01087749

    Pharmacokinetic Study in Patients With Chronic Kidney Disease and Healthy Volunteers

    Not yet reported University of California, San Francisco 24 participants Est. completion 2012-12 1 site Stand-alone
    Other conditions: Kidney Disease
    View official trial listing →
  • Completed NCT NCT01102465

    Bioequivalency Study of Losartan Potassium/Hydrochlorothiazide 100 mg /25 mg Tablet Under Fed Conditions

    Not yet reported Roxane Laboratories 25 participants Est. completion 2005-03 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01102478

    Bioequivalency Study of Losartan Potassium/Hydrochlorothiazide 100 mg/25 mg Tablet Under Fasted Conditions

    Not yet reported Roxane Laboratories 30 participants Est. completion 2005-03 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01115426

    Inhibitors of Angiotensin II in Proteinuric Mesangioproliferative Glomerulonephritis

    Not yet reported University Magna Graecia 20 participants Est. completion 2008-01 1 site
    Other conditions: IGA Glomerulonephritis
    View official trial listing →
  • Completed NCT NCT01124162

    Losartan 100 mg Tablets in Healthy Subjects Under Fasting Conditions

    Not yet reported Teva Pharmaceuticals USA 80 participants Est. completion 2003-11 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01124175

    Losartan 100 mg Tablet in Healthy Subjects Under Non-Fasting Conditions

    Not yet reported Teva Pharmaceuticals USA 80 participants Est. completion 2003-11 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01127217

    Efficacy/Safety of Amlodipine Plus Losartan Versus Amlodipine in Patients With Stage 2 Hypertension

    Not yet reported Hanmi Pharmaceutical Company Limited 149 participants Est. completion 2010-03 1 site Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Status unknown NCT NCT01145612

    Atenolol Versus Losartan in the Prevention of Progressive Dilation of the Aorta in Marfan Syndrome

    Not yet reported Forteza, Albert, M.D. 140 participants Est. completion 2013-02 2 sites Stand-alone
    Other conditions: Marfan Syndrome
    View official trial listing →
  • Completed NCT NCT01149473

    Losartan Potassium/Hydrochlorothiazide 100/25 mg Tablets in Healthy Subjects Under Non-Fasting Conditions

    Not yet reported Teva Pharmaceuticals USA 80 participants Est. completion 2004-04 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01149486

    Losartan Potassium/Hydrochlorothiazide 100/25 mg Tablets in Healthy Subjects Under Fasting Conditions

    Not yet reported Teva Pharmaceuticals USA 20 participants Est. completion 2004-02 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01150201

    Aliskiren Combined With Losartan in Proteinuric, Non-diabetic Chronic Kidney Disease

    Not yet reported The University of Hong Kong 80 participants Est. completion 2014-08 1 site
    Other conditions: Kidney Disease
    View official trial listing →
  • Completed NCT NCT01150461

    Effect of Losartan in Patients With Nonobstructive Hypertrophic Cardiomyopathy

    Not yet reported Massachusetts General Hospital 20 participants Est. completion 2010-07 1 site Stand-alone
    Other conditions: Hypertrophic Cardiomyopathy
    View official trial listing →
  • Completed NCT NCT01176032

    ALiskiren or Losartan Effects on bioMARKers of Myocardial Remodeling

    Not yet reported Novartis Pharmaceuticals 74 participants Est. completion 2013-04 25 sites
    Other conditions: Hypertension, Left Ventricle Hypertrophy
    View official trial listing →
  • Completed NCT NCT01180413

    Intensive Vasodilator Therapy in Patients With Essential Hypertension

    Not yet reported Aarhus University Hospital 48 participants Est. completion 2012-04 1 site Stand-alone
    Other conditions: Essential Hypertension, High Blood Pressure
    View official trial listing →
  • Completed NCT NCT01187862

    Pharmacokinetic Study to Investigate Low-dose Combinations of a Cocktail of Seven Drugs for Simultaneous Phenotyping of Cytochromes

    Not yet reported University Hospital, Basel, Switzerland 16 participants 1 site
    Other conditions: Cytochrome, Pharmacokinetics
    View official trial listing →
  • Completed NCT NCT01197001

    A Bioequivalence Study of Amlodipine Plus Losartan Versus Amlodipine and Losartan

    Not yet reported Hanmi Pharmaceutical Company Limited 72 participants Est. completion 2010-11 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01197014

    A Bioequivalence Study of Amlodipine Plus Losartan Versus Amlodipine and Losartan

    Not yet reported Hanmi Pharmaceutical Company Limited 72 participants Est. completion 2010-12 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01198249

    Pharmacokinetic Drug Interactions Between Single and Concomitant Administrations of Amlodipine, Losartan, and Hydrochlorothiazide in Subjects With (Pre)Hypertension

    Not yet reported Yonsei University 23 participants Est. completion 2011-03 1 site Stand-alone
    Other conditions: Essential Hypertension
    View official trial listing →
  • Status unknown NCT NCT01198496

    Recurrent Stroke Prevention Clinical Outcome Study

    Not yet reported Biomedis International Ltd. 5000 participants Est. completion 2019-12 1 site Stand-alone
    Cardiovascular disease Other conditions: Hypertension, Blood Pressure
    View official trial listing →
  • Active, not recruiting NCT NCT01199978

    Hearing Outcomes Using Fractionated Proton Radiation Therapy for Vestibular Schwannoma

    Not yet reported Massachusetts General Hospital 30 participants Est. completion 2026-12 1 site
    Other conditions: Vestibular Schwannoma, Acoustic Neuroma
    View official trial listing →
  • Completed NCT NCT01210430

    Local Vasoconstriction in Postural Tachycardia Syndrome

    Not yet reported New York Medical College 74 participants Est. completion 2015-06 1 site
    Other conditions: Postural Tachycardia Syndrome
    View official trial listing →
  • Completed NCT NCT01216852

    Bioequivalency Study of Losartan Potassium 100 mg Tablet Under Fasted Conditions

    Not yet reported Roxane Laboratories 40 participants Est. completion 2004-08 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01216878

    Bioequivalency Study of Losartan Potassium 100 mg Tablet Under Fed Conditions

    Not yet reported Roxane Laboratories 40 participants Est. completion 2004-09 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01218022

    Bioequivalence Study of Losartan Potassium (100 mg Tablet) [Test Formulation, Torrent Pharmaceuticals Ltd., India] Versus Cozaar® (100 mg Tablet) [Reference Formulation, Merck & Co. Inc., USA] in Healthy Human Volunteers Under Fasting Condition

    Not yet reported Torrent Pharmaceuticals Limited 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01218698

    Bioequivalence Study of Losartan Potassium (100 mg Tablet) [Test Formulation, Torrent Pharmaceuticals Ltd., India] Versus Cozaar® (100 mg Tablet) [Reference Formulation, Merck & Co. Inc., USA] in Healthy Human Volunteers Under Fed Condition

    Not yet reported Torrent Pharmaceuticals Limited 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01218711

    Bioequivalence Study of Losartan Potassium and Hydrochlorothiazide (100 mg / 25 mg Tablet) [Test Formulation, Torrent Pharmaceuticals Ltd., India] Versus Hyzaar® (100 mg / 25 mg Tablet) [Reference Formulation, Merck & Co., Inc., USA] in Healthy Human Volunteers Under Fasting Conditions.

    Not yet reported Torrent Pharmaceuticals Limited
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01218724

    Bioequivalence Study of Losartan Potassium and Hydrochlorothiazide (100 mg / 25 mg Tablet) [Test Formulation, Torrent Pharmaceuticals Ltd., India] Versus Hyzaar® (100 mg / 25 mg Tablet) [Reference Formulation, Merck & Co., Inc., USA] in Healthy Human Volunteers Under Fed Conditions

    Not yet reported Torrent Pharmaceuticals Limited 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01224860

    Telmisartan Versus Losartan in Kidney Transplantation

    Not yet reported Mario Negri Institute for Pharmacological Research 20 participants Est. completion 2014-01 1 site Stand-alone
    Other conditions: Renal Transplant
    View official trial listing →
  • Terminated NCT NCT01230216

    Effect of Intensive Blood Pressure Control on Progression of Coronary Atherosclerosis: Randomized Evaluation by Intravascular Ultrasound

    Not yet reported Takeshi Morimoto 8 participants Est. completion 2015-04 1 site
    Cardiovascular disease Other conditions: Hypertension
    View official trial listing →
  • Terminated NCT NCT01233635

    Secondary Prevention of Atrial Fibrillation (Impact of Renin-Angiotensin-Aldosterone System Inhibition)

    Not yet reported University of Pittsburgh 228 participants Est. completion 2007-11 1 site
    Other conditions: Atrial Fibrillation
    View official trial listing →
  • Terminated NCT NCT01234922

    Benazepril Hydrochloride, Lisinopril, Ramipril, or Losartan Potassium in Treating Hypertension in Patients With Solid Tumors

    Not yet reported Wake Forest University Health Sciences 6 participants Est. completion 2014-04 1 site Stand-alone
    Other conditions: Hypertension, Unspecified Adult Solid Tumor, Protocol Specific
    View official trial listing →
  • Status unknown NCT NCT01271374

    Changes in Endothelial Function and Biomarkers in African Americans (AA) With Metabolic Syndrome

    Not yet reported InVasc Therapeutics, Inc. 80 participants Est. completion 2011-12 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Terminated NCT NCT01276613

    Tissue Pharmacokinetics of Intraoperative Gemcitabine in Resectable Adenocarcinoma of the Pancreas

    Not yet reported M.D. Anderson Cancer Center 18 participants Est. completion 2019-04-19 1 site Stand-alone
    Other conditions: Pancreatic Cancer
    View official trial listing →
  • Completed NCT NCT01277822

    Efficacy of Losartan + Amlodipine Compared to Amlodipine Alone in the Treatment of Uncontrolled High Blood Pressure (MK-0954F-399)

    Not yet reported Organon and Co 334 participants Est. completion 2013-04-22 Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01281787

    PREvention of Atrial Fibrillation in patientS Undergoing thorAcic surGEry for Lung Cancer

    Not yet reported European Institute of Oncology 320 participants Est. completion 2013-10 1 site
    Other conditions: Lung Cancer, Atrial Fibrillation
    View official trial listing →
  • Terminated NCT NCT01292694

    Contribution of Angiotensin II to Supine Hypertension in Autonomic Failure

    Not yet reported Vanderbilt University 12 participants Est. completion 2017-03 1 site Stand-alone
    Other conditions: Hypertension, Pure Autonomic Failure, Multiple System Atrophy
    View official trial listing →
  • Completed NCT NCT01302691

    MK-0954E Study in Participants With Hypertension (MK-0954E-357)

    Not yet reported Merck Sharp & Dohme LLC 327 participants Est. completion 2012-04-01 Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Status unknown NCT NCT01305850

    The Effect of Aliskiren and Losartan on Peritoneal Membrane in Continuous Ambulatory Peritoneal Dialysis Patients

    Not yet reported Chulalongkorn University 100 participants Est. completion 2011-10 1 site
    Other conditions: Peritoneal Membrane Failure
    View official trial listing →
  • Completed NCT NCT01307033

    A Long-term Study of the Safety of MK-0954A in Patients With Essential Hypertension (MK-0954A-351)

    Not yet reported Organon and Co 278 participants Est. completion 2012-12-04 Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01307046

    MK-0954A in Japanese Patients With Essential Hypertension Not Adequately Controlled With Losartan (MK-0954A-352)

    Not yet reported Organon and Co 336 participants Est. completion 2012-02-07 Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Status unknown NCT NCT01320397

    Antihypertensive Effect of Rostafuroxin Compared With Losartan in Hypertensive Patients Bearing Specified Gene Mutations

    Not yet reported RostaQuo S.p.A. 240 participants Est. completion 2012-12 26 sites Stand-alone
    Other conditions: Essential Hypertension
    View official trial listing →
  • Completed NCT NCT01321021

    Influence of Losartan and Diphenhydramine on Emotional and Cognitive Functions in Healthy Human Subjects

    Not yet reported Prof. Dominique de Quervain, MD 80 participants Est. completion 2011-08 1 site Stand-alone
    Other conditions: Memory, Long-Term, Memory, Short-Term
    View official trial listing →
  • Completed NCT NCT01324752

    A Drug-Drug Interaction Study of Losartan and PA21

    Not yet reported Vifor Pharma 36 participants Est. completion 2011-06 1 site Stand-alone
    Other conditions: Drug Interaction Potentiation
    View official trial listing →
  • Withdrawn NCT NCT01361087

    Circulating Transforming Growth Factor Beta (TGF-β) in Individuals With Marfan Syndrome

    Not yet reported Ann & Robert H Lurie Children's Hospital of Chicago 1 site
    Other conditions: Marfan Syndrome
    View official trial listing →
  • Completed NCT NCT01368185

    Impact of MK-0954A on Uric Acid in the Management of Hypertension (MK-0954A-366)

    Organon and Co 1705 participants Est. completion 2010-08
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01371747

    Patiromer in the Treatment of Hyperkalemia in Patients With Hypertension and Diabetic Nephropathy (AMETHYST-DN)

    Not yet reported Relypsa, Inc. 324 participants Est. completion 2013-06 43 sites Stand-alone
    Chronic kidney disease Other conditions: Hypertension, Hyperkalemia
    View official trial listing →
  • Completed NCT NCT01384591

    Pilot Study of Losartan and N-acetylcysteine as Inhibitors of Muscle Oxidative Stress in Elderly

    Not yet reported, Not yet reported The University of Texas Medical Branch, Galveston 6 participants Est. completion 2015-05 1 site Stand-alone
    Other conditions: Aging
    View official trial listing →
  • Terminated NCT NCT01390181

    The Effect of Losartan in Bicuspid Aortic Valve Patients

    Not yet reported University of Michigan 4 participants Est. completion 2014-01 1 site Stand-alone
    Other conditions: Bicuspid Aortic Valve, Thoracic Aortic Aneurysm
    View official trial listing →
  • Completed NCT NCT01390415

    A Study to Evaluate Whether Losartan Protects the Kidney in Hypertensive Diabetic Participants With Microalbuminuria (MK0954-365 AM1)

    Organon and Co 136 participants Est. completion 2010-08
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01398423

    INV-144 Versus Losartan in Hypertension and Type 2 Diabetes Mellitus Patients With Macroalbuminuria

    Not yet reported InVasc Therapeutics, Inc. 88 participants Est. completion 2012-07 19 sites Stand-alone
    Type 2 diabetes Other conditions: Hypertension
    View official trial listing →
  • Withdrawn NCT NCT01409408

    Comparison of Amlodipine and Aliskiren in Diabetic Hypertensive Patient With Blood Pressure Not Controlled by Losartan

    Not yet reported Hospital Universitario Pedro Ernesto Est. completion 2013-12 1 site
    Other conditions: Hypertension, Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT01431508

    A Study of Safety and Efficacy in MK-0954A Combination in Participants With Hypertension (MK-0954A-373 AM3)

    Not yet reported Organon and Co 15 participants Est. completion 2009-06-01 Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01443039

    Phenotypical Approach of the Drug Metabolizing Hormones Activity Before and After Roux-en Y-Gastric Bypass

    Not yet reported Assistance Publique - Hôpitaux de Paris 11 participants Est. completion 2014-02 1 site Stand-alone
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT01447654

    Inhibition of the Renin Angiotensin System With Losartan in Patients With Hypertrophic Cardiomyopathy

    Not yet reported Henning Bundgaard 130 participants Est. completion 2014-06 1 site
    Other conditions: Hypertrophic Cardiomyopathy
    View official trial listing →
  • Completed NCT NCT01479439

    Losartan to Reverse Sickle Nephropathy

    Not yet reported Children's Hospital Medical Center, Cincinnati 36 participants Est. completion 2015-12 9 sites Stand-alone
    Other conditions: Nephropathy, Sickle Cell Anemia
    View official trial listing →
  • Completed NCT NCT01529749

    Effects of Losartan and Antiretroviral Regimen Containing Raltegravir in Fibrosis Inflammation Mediators, Cardiovascular Risk and Neurocognitive Disorders in HIV Infected Patients Previously Effectively Treated

    Not yet reported Felipe Garcia 48 participants Est. completion 2016-02 1 site Stand-alone
    Other conditions: HIV-1 Infection
    View official trial listing →
  • Completed NCT NCT01541943

    Efficacy and Safety of HL-040XC in Essential Hypertension and Hyperlipidemia

    Not yet reported HanAll BioPharma Co., Ltd. 356 participants Est. completion 2014-11 1 site
    Other conditions: Essential Hypertension, Hyperlipidemia
    View official trial listing →
  • Completed NCT NCT01570569

    Development of Minidose Inje Cocktail Method for Simultaneous Evaluating Five Cytochrome P450 Isoforms in Human

    Not yet reported Inje University 26 participants Est. completion 2011-03
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01603940

    Comparison Between Losartan and Benazepril in Diabetic Hypertensive Patients Not Controlled by Amlodipine

    Not yet reported Hospital Universitario Pedro Ernesto 30 participants Est. completion 2015-01 1 site
    Other conditions: Hypertension, Diabetes Mellitus
    View official trial listing →
  • Suspended NCT NCT01620788

    Comparison of Losartan Associated With Indapamide Versus Hyzaar® in the Hypertension Treatment

    Not yet reported EMS 636 participants Est. completion 2023-10 1 site Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01637623

    Study of Cardiovascular Disease and Obstructive Sleep Apnea

    Not yet reported University of Wisconsin, Madison 87 participants Est. completion 2015-06 4 sites
    Obstructive sleep apnea Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01648231

    Crossover Study to Evaluate the Comparative Bioavailability of Two Fixed Dose Combination Tablet Formulations of Amlodipine and Losartan in Health Volunteers

    Not yet reported GlaxoSmithKline 23 participants Est. completion 2012-09-25 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01667614

    Effects of Spironolactone Combination Therapy on Proteinuria, Kidney Function, and Blood Pressure

    Not yet reported Tehran University of Medical Sciences 136 participants Est. completion 2012-07 1 site
    Type 2 diabetesChronic kidney disease Other conditions: Essential Hypertension
    View official trial listing →
  • Completed NCT NCT01675362

    Are There Protective Effects of Antioxidants, Calcium Channel Blocker and Angiotensin Receptor Blocker Against Extracorporeal Shockwaves Lithotripsy Induced Renal Injury?

    Not yet reported Mansoura University 160 participants Est. completion 2014-10 1 site
    Other conditions: Kidney Calculi
    View official trial listing →
  • Completed NCT NCT01692717

    Clinical Assessment Of Association Pharmacokinetics Atorvastatin + Losartana + Hydrochlorothiazide

    Not yet reported Azidus Brasil 90 participants Est. completion 2013-05-31 1 site Stand-alone
    Other conditions: Healthy Subjects
    View official trial listing →
  • Completed NCT NCT01713647

    Bioequivalence Study of Amlodipine / Losartan/ Hydrochlorothiazide of PHARMALINE, Lebanon Under Fastion Conditions

    Not yet reported Pharmaceutical Research Unit, Jordan 39 participants Est. completion 2012-12 1 site Stand-alone
    Other conditions: Fasting
    View official trial listing →
  • Status unknown NCT NCT01715584

    Is There an Adverse Drug Reaction Between Renin-Angiotensin System Blockade and Inhaled Anesthetics

    Not yet reported London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 80 participants Est. completion 2019-12-31 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01766050

    Study to Evaluate Effect of Belatacept on Pharmacokinetics of Inje Cocktail in Healthy Volunteers

    Not yet reported Bristol-Myers Squibb 45 participants Est. completion 2013-04 1 site Stand-alone
    Other conditions: Transplant Rejection
    View official trial listing →
  • Terminated NCT NCT01766505

    The Study to Evaluate Efficacy and Safety of Candesartan vs Losartan in Hypertension With Heart Failure (HONOR)

    Not yet reported Chong Kun Dang Pharmaceutical 32 participants Est. completion 2014-03 9 sites
    Other conditions: Hypertension
    View official trial listing →
  • Status unknown NCT NCT01774656

    Remission From Stage D Heart Failure

    Not yet reported University of Louisville 40 participants Est. completion 2017-12 6 sites Stand-alone
    Heart failure
    View official trial listing →
  • Completed NCT NCT01797926

    Study to Determine the Bioequivalence of Two Fixed Dose Combination (FDC) Tablet Formulations of Amlodipine and Losartan FDC5/50 and FDC5/100 Under Fasting Conditions

    Not yet reported GlaxoSmithKline 102 participants Est. completion 2013-07-25 1 site Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01805453

    Angiotensin II Receptor Blockers, Steroids and Radiotherapy in Glioblastoma

    Not yet reported Assistance Publique - Hôpitaux de Paris 80 participants Est. completion 2017-05-15 1 site
    Other conditions: Newly-diagnosed Glioblastoma
    View official trial listing →
  • Completed NCT NCT01806324

    A Study to Evaluate Pharmacokinetics and Potential Drug Interactions of a Fixed-dose Combination Tablet, HL-040XC, in Healthy Male Subjects

    Not yet reported HanAll BioPharma Co., Ltd. 30 participants Est. completion 2012-12 1 site Stand-alone
    Other conditions: Hypertension, Hyperlipidemia
    View official trial listing →
  • Completed NCT NCT01808196

    Testing Effectiveness of Losartan in Patients With EoE With or Without a CTD

    Not yet reported Children's Hospital Medical Center, Cincinnati 6 participants Est. completion 2015-02-13 1 site Stand-alone
    Other conditions: Eosinophilic Esophagitis, Connective Tissue Disorders
    View official trial listing →
  • Completed NCT NCT01821729

    Radiation w/FOLFIRINOX-Losartan for Pancreatic Cancer

    Not yet reported Massachusetts General Hospital 50 participants Est. completion 2022-05-11 1 site Stand-alone
    Other conditions: Pancreatic Cancer
    View official trial listing →
  • Completed NCT NCT01828359

    The Efficacy and Safety Study of Anti-hypertension Combination Drug in Patients Uncontrolled With Monotherapy.

    Not yet reported Hanmi Pharmaceutical Company Limited 199 participants Est. completion 2013-01 Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01830517

    Diurnal Variation in Hypertensive Stroke Patients

    Not yet reported Hanmi Pharmaceutical Company Limited 84 participants Est. completion 2012-02 1 site Stand-alone
    Cardiovascular disease Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01845688

    Clinical Study of QingReMoShen Granule to Treat Idiopathic Membranous Nephropathy

    Not yet reported wanglin 72 participants Est. completion 2016-09 1 site Stand-alone
    Other conditions: Idiopathic Membranous Nephropathy
    View official trial listing →
  • Completed NCT NCT01852942

    Reversing Tissue Fibrosis to Improve Immune Reconstitution in HIV

    Not yet reported University of Minnesota 52 participants Est. completion 2019-07-16 1 site Stand-alone
    Other conditions: HIV Infection, HIV Infections
    View official trial listing →
  • Completed NCT NCT01854814

    The Effects of Mycophenolate Mofetil (MMF) on Renal Outcomes in Advanced Immunoglobulin A (IgA) Nephropathy Patients

    Not yet reported Fan Fan Hou 238 participants Est. completion 2022-05 3 sites Stand-alone
    Other conditions: IgA Nephropathy
    View official trial listing →
  • Completed NCT NCT01857999

    Losartan in Decompensated Heart Failure

    Not yet reported InCor Heart Institute 21 participants Est. completion 2011-03 1 site Stand-alone
    Heart failure Other conditions: Low Cardiac Output
    View official trial listing →
  • Completed NCT NCT01858623

    Pharmacokinetic Interactions of Losartan and Hydrochlorothiazide

    Not yet reported Damanhour University 18 participants Est. completion 2013-03
    Other conditions: Healthy Normotensive Participants
    View official trial listing →
  • Completed NCT NCT01891513

    ACE Inhibitors Combined With Exercise for Seniors - Pilot Study

    University of Florida 104 participants Est. completion 2017-06 1 site
    Other conditions: Hypertension, Aging
    View official trial listing →
  • Completed NCT NCT01913470

    Study of Losartan in the Treatment of NAFLD in Children

    Not yet reported Miriam Vos, MD 12 participants Est. completion 2015-12 1 site Stand-alone
    MASLD
    View official trial listing →
  • Completed NCT NCT01934569

    Drug-Drug Interaction Study With PF-05089771

    Not yet reported Pfizer 17 participants Est. completion 2013-11 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01964079

    Comparision of Blood Pressure Variability Between Amlodipine and Losartan

    Not yet reported Wonju Severance Christian Hospital 144 participants Est. completion 2017-05 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01982695

    Cardiomyopathy in DMD: Lisinopril vs. Losartan

    Not yet reported Nationwide Children's Hospital 23 participants Est. completion 2013-09 6 sites
    Other conditions: Duchenne Muscular Dystrophy (DMD), Cardiomyopathy
    View official trial listing →
  • Completed NCT NCT01989078

    Losartan for Sickle Cell Kidney Disease

    Not yet reported Emory University 24 participants Est. completion 2016-12 2 sites Stand-alone
    Other conditions: Sickle Cell Disease
    View official trial listing →
  • Completed NCT NCT01989793

    A Study of Muscle Strength Maintenance in Older Adults

    Not yet reported Johns Hopkins University 37 participants Est. completion 2016-10 1 site
    Other conditions: Sarcopenia
    View official trial listing →
  • Status unknown NCT NCT02010905

    Right Ventricular Dysfunction in Tetralogy of Fallot: Inhibition of the Renin-angiotensin-aldosterone System

    Not yet reported Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 120 participants Est. completion 2018-01 6 sites
    Other conditions: Tetralogy of Fallot, Heart Defects, Congenital, Ventricular Dysfunction, Right
    View official trial listing →
  • Completed NCT NCT02049307

    Losartan to Reduce Inflammation and Fibrosis Endpoints in HIV Trial

    Not yet reported Hennepin Healthcare Research Institute 108 participants Est. completion 2018-12-14 4 sites
    Other conditions: Inflammation, Fibrosis
    View official trial listing →
  • Completed NCT NCT02056743

    Clinical Trials on Evaluate the Red Ginseng and Fermented-Red Ginseng Affect to Drug Metabolizing Enzyme and Transporter in Healthy Volunteers

    Not yet reported Chonbuk National University Hospital 30 participants 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT02063100

    Efficacy and Safety of Shenyankangfu Tablets for Primary Glomerulonephritis

    Not yet reported Chinese PLA General Hospital 720 participants 43 sites Stand-alone
    Other conditions: Glomerulonephritis, Proteinuria
    View official trial listing →
  • Completed NCT NCT02121041

    Ambulatory vs Office BP Management Usual Care for Diagnosing and Managing Hypertension: A Pilot Study

    Not yet reported Anthony J Viera, MD, MPH 28 participants Est. completion 2016-07 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Status unknown NCT NCT02140489

    Evaluating a Pharmacokinetic Drug Interaction Between Amlodipine/Losartan and Rosuvastatin

    Not yet reported Hanmi Pharmaceutical Company Limited 30 participants Est. completion 2014-08 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02166398

    A Randomized, Open-label, Single Dose, Two-way Crossover Clinical Trial to Compare the Safety, Pharmacokinetic Profiles of UI15AML055MT and Amosartan® Tablet 5/50 mg After a Single Oral Administration in Healthy Male Volunteers

    Not yet reported Korea United Pharm. Inc. 46 participants Est. completion 2014-12 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02172586

    Telmisartan With or Without Hydrochlorothiazide (HCTZ) Compared With Losartan With or Without HCTZ in Mild to Moderate Hypertensive Patients

    Not yet reported Boehringer Ingelheim 363 participants
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02183701

    Telmisartan Compared to Losartan + Hydrochlorothiazide in Patients With Mild-to-moderate Essential Hypertension

    Not yet reported Boehringer Ingelheim 715 participants
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02188121

    Fixed Dose Intervention Trial of New England Enhancing Survival in SMI Patients

    Not yet reported Mclean Hospital 227 participants Est. completion 2021-10 1 site Stand-alone
    Cardiovascular disease Other conditions: Serious Mental Illness, Schizophrenia, Schizoaffective Disorder, Bipolar Disorder, Major Depressive Disorder, Psychosis NOS
    View official trial listing →
  • Status unknown NCT NCT02190318

    Residual Renal Function Preservation in Peritoneal Dialysis Patients

    Not yet reported Second Xiangya Hospital of Central South University 96 participants Est. completion 2015-12 1 site Stand-alone
    Other conditions: Chronic Renal Disease
    View official trial listing →
  • Completed NCT NCT02200640

    A Trial Comparing MICARDIS® (Telmisartan) and COZAAR® (Losartan) in Patients With Mild-to-Moderate Hypertension Using Ambulatory Blood Pressure Monitoring (ABPM)

    Not yet reported Boehringer Ingelheim 333 participants
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02200653

    A Trial Comparing MICARDIS® (Telmisartan) and COZAAR® / LORZAAR® (Losartan) in Patients With Mild-to-Moderate Hypertension Using Ambulatory Blood Pressure Monitoring (ABPM)

    Not yet reported Boehringer Ingelheim 387 participants
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02212769

    the Pharmacokinetic Profiles of Losartan With DW1029M

    Not yet reported Dong Wha Pharmaceutical Co. Ltd. 12 participants Est. completion 2015-02 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT02231125

    Efficacy and Safety of Abelmoschus Manihot for IgA Nephropathy

    Not yet reported Chen Xiangmei 1600 participants Est. completion 2017-12 88 sites Stand-alone
    Other conditions: IgA Nephropathy
    View official trial listing →
  • Completed NCT NCT02232763

    Efficacy and Safety of Losartan in Pediatric Chronic Kidney Disease With Tubular Proteinuria

    Not yet reported Seoul National University Hospital 58 participants Est. completion 2016-09 1 site Stand-alone
    Other conditions: Proteinuria
    View official trial listing →
  • Completed NCT NCT02232776

    Efficacy and Safety of Losartan in Children With Ig A Nephropathy

    Not yet reported Seoul National University Hospital 37 participants Est. completion 2017-04 1 site Stand-alone
    Other conditions: Glomerulonephritis, IGA
    View official trial listing →
  • Terminated NCT NCT02232880

    Treatment of Resistant Hypertension by Prevention of T-Cell Co-Stimulation

    Not yet reported Vanderbilt University Medical Center 1 participants Est. completion 2015-06 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02235909

    An Efficacy and Safety Study in Children 6 to Less Than 18 Years of Age With Hypertension

    Not yet reported Arbor Pharmaceuticals, Inc. 377 participants Est. completion 2019-11-11 69 sites Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Withdrawn NCT NCT02238457

    Study of High Dosage of Losartan in Comparison to Low Dose of Losartan in Heart Failure Patients

    Not yet reported Baker Heart and Diabetes Institute
    Heart failure
    View official trial listing →
  • Status unknown NCT NCT02246257

    Early Rheumatoid Arthritis COR Intervention

    Not yet reported MD, PhD, Annemarie Lyng Svensson 300 participants Est. completion 2024-09 1 site
    Cardiovascular disease Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT02248961

    Efficacy and Safety Evaluating Study to Compare Kanarb (Fimasartan) and Cozaar® (Losartan) in Adult Patients With Grade I-II Arterial Hypertension

    Not yet reported R-Pharm 179 participants Est. completion 2015-08 13 sites
    Other conditions: Arterial Hypertension
    View official trial listing →
  • Terminated NCT NCT02263729

    Phase 1/2 Prospective Double-Blind Placebo-Controlled Randomized Clinical Trial of Losartan to Treat Grade II & III Hamstring Strains

    Not yet reported, Not yet reported James J. Irrgang 8 participants Est. completion 2022-12-31 1 site
    Other conditions: Hamstring Injury
    View official trial listing →
  • Completed NCT NCT02269176

    Efficacy and Safety of Telmisartan and Losartan in Primary Hypertension

    Not yet reported Boehringer Ingelheim 330 participants
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02278471

    The SCCS Polypill Pilot Trial

    Not yet reported Vanderbilt University 303 participants Est. completion 2018-06-27 1 site Stand-alone
    Other conditions: Hypertension, Hyperlipidemia
    View official trial listing →
  • Completed NCT NCT02294539

    Comparison of Effects Between Amlodipine and Hydrochlorothiazide in Combination With Losartan on 24-hr Central Blood Pressure in Hypertensive Patients

    Not yet reported Chong-Jin Kim 231 participants Est. completion 2016-05-18 1 site Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02355821

    Comparative Effects of Moxonidine on Bone Metabolism, Vascular and Cellular Aging in Hypertensive Postmenopausal Women

    Not yet reported National Research Center for Preventive Medicine 114 participants Est. completion 2018-07-10 1 site Stand-alone
    Other conditions: Osteopenia, Arterial Hypertension
    View official trial listing →
  • Terminated NCT NCT02373241

    Preventing Sickle Cell Kidney Disease

    Not yet reported University of Alabama at Birmingham 1 participants Est. completion 2021-07 1 site Stand-alone
    Other conditions: Anemia, Sickle Cell, Sickle Cell Disease, Kidney Disease, Hypertension, Proteinuria
    View official trial listing →
  • Completed NCT NCT02387554

    Pharmacokinetic Interaction Between HGP0904, HGP0608 and HGP1405

    Not yet reported Hanmi Pharmaceutical Company Limited 33 participants Est. completion 2014-10 1 site Stand-alone
    Other conditions: Hypertension(HTN)
    View official trial listing →
  • Terminated NCT NCT02410005

    Intervention Using Vitamin D for Elevated Urinary Albumin Treated With Losartan in Diabetes (IDEAL)

    Not yet reported, Not yet reported Weill Cornell Medical College in Qatar 56 participants Est. completion 2015-09-07 3 sites Stand-alone
    Other conditions: Diabetic Nephropathies
    View official trial listing →
  • Terminated NCT NCT02416102

    Effect of Losartan on Airway Mucociliary Dysfunction in Patients With COPD and Chronic Bronchitis

    Not yet reported University of Miami 31 participants Est. completion 2017-04-03 1 site Stand-alone
    Other conditions: COPD, Chronic Bronchitis
    View official trial listing →
  • Completed NCT NCT02446548

    Influence of Aliskiren on Albuminuria After Kidney Transplantation

    Not yet reported Medical University of Gdansk 18 participants Est. completion 2014-11 1 site Stand-alone
    Other conditions: Albuminuria
    View official trial listing →
  • Completed NCT NCT02504606

    Safety and Pharmacokinetics of Besylsartan Tablet in Healthy Male Subject

    Not yet reported Huons Co., Ltd. 60 participants Est. completion 2014-10 Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Withdrawn NCT NCT02521233

    Efficacy and Safety of Candesartan Associated With Chlorthalidone in Essential Arterial Hypertension Control

    Not yet reported EMS Est. completion 2017-08
    Other conditions: Essential Arterial Hypertension
    View official trial listing →
  • Withdrawn NCT NCT02521246

    Efficacy and Safety of Candesartan Associated With Chlorthalidone Versus Losartan Associated With Hydrochlorothiazide (Hyzaar®) in Essential Hypertension Control

    Not yet reported EMS Est. completion 2017-08
    Other conditions: Essential Arterial Hypertension
    View official trial listing →
  • Completed NCT NCT02620306

    A Randomized, Double-blind, Active Control, Parallel Group, Titration, Multicenter Study to Evaluate the Efficacy and Safety of Fimasartan

    Not yet reported Boryung Pharmaceutical Co., Ltd 351 participants Est. completion 2022-05-11 1 site
    Chronic kidney disease
    View official trial listing →
  • Completed NCT NCT02663141

    Randomized Clinical Trial of Intravitreal Bevacizumab Versus Intravitreal Bevacizumab Combined With Losartan in the Treatment of Diabetic Macular Edema

    Not yet reported Tehran University of Medical Sciences 57 participants Est. completion 2016-06 1 site Stand-alone
    Other conditions: Diabetic Macular Edema
    View official trial listing →
  • Completed NCT NCT02676466

    The ENRGISE (ENabling Reduction of Low-Grade Inflammation in SEniors) Pilot Study

    Not yet reported University of Florida 289 participants Est. completion 2018-06-22 5 sites
    Other conditions: Inflammation
    View official trial listing →
  • Completed NCT NCT02696564

    Losartan Effects on Emphysema Progression

    Not yet reported JHSPH Center for Clinical Trials 220 participants Est. completion 2021-06-30 28 sites
    Other conditions: Emphysema
    View official trial listing →
  • Completed NCT NCT02704494

    Resveratrol's Effects in Diabetic Nephropathy

    Not yet reported Shiraz University of Medical Sciences 60 participants Est. completion 2017-02 1 site Stand-alone
    Chronic kidney disease
    View official trial listing →
  • Completed NCT NCT02709018

    A Controlled Trial of Losartan in Posttraumatic Stress Disorder

    Not yet reported University of California, San Diego 149 participants Est. completion 2020-09-29 6 sites Stand-alone
    Other conditions: Posttraumatic Stress Disorder
    View official trial listing →
  • Completed NCT NCT02744456

    N-of-1 Trials for Blood Pressure Medications in Adults

    Not yet reported Columbia University 10 participants Est. completion 2017-12-31 1 site
    Other conditions: Hypertension, High Blood Pressure
    View official trial listing →
  • Withdrawn NCT NCT02760615

    Phase 4, Vedolizumab-4002 Post-marketing, Disease-Drug-Drug Interaction Study

    Not yet reported Takeda Est. completion 2020-08-01 2 sites Stand-alone
    Other conditions: Colitis, Ulcerative, Crohn Disease
    View official trial listing →
  • Completed NCT NCT02768948

    Telmisartan Promotes the Differentiation of Monocytes Into Macrophages M2 in Diabetic Nephropathy?

    Not yet reported Centre Hospitalier Universitaire de Nice 20 participants Est. completion 2020-07-11 1 site Stand-alone
    Chronic kidney disease
    View official trial listing →
  • Suspended NCT NCT02769130

    Pilot Trial: the Safety and Feasibility of Losartan for Pulmonary Vein Stenosis

    Not yet reported, Not yet reported The Hospital for Sick Children 40 participants Est. completion 2021-05 1 site Stand-alone
    Other conditions: Pulmonary Vein Stenosis, Children
    View official trial listing →
  • Status unknown NCT NCT02900729

    Randomized Controlled Trial of Renal Denervation for Resistant Hypertension

    Not yet reported Shanghai WiseGain Medical Devices Co., Ltd. 254 participants Est. completion 2018-02 13 sites Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02913664

    Risk Reduction for Alzheimer's Disease

    Not yet reported, Not yet reported University of Texas Southwestern Medical Center 513 participants Est. completion 2022-01-31 4 sites Stand-alone
    Other conditions: Cognitively Normal Older Adults, Hypertension, Subjective Cognitive Decline, Family History of Alzheimer's Disease
    View official trial listing →
  • Completed NCT NCT02916602

    A Study to Evaluate Efficacy and Safety of HCP1401 for Stage 2 Hypertension Patients Not Controlled by HCP0605

    Not yet reported Hanmi Pharmaceutical Company Limited 340 participants Est. completion 2016-09 1 site Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Status unknown NCT NCT02958631

    Comparison of Blood Pressure Lowering Effect Between Fimasartan and Losartan

    Not yet reported Chuncheon Sacred Heart Hospital 40 participants Est. completion 2017-04
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT03006952

    Add-on Pentoxifylline to Losartan Versus Increasing Dose of Losartan on NT-PRO BNP in Type 2 Diabetics With Nephropathy

    Not yet reported Tehran University of Medical Sciences 59 participants Est. completion 2015-09 1 site
    Other conditions: Diabetic Nephropathies
    View official trial listing →
  • Completed NCT NCT03029091

    An Open-Label Trial of Losartan Potassium in Participants With Eosinophilic Esophagitis (EoE)

    Not yet reported Children's Hospital Medical Center, Cincinnati 15 participants Est. completion 2019-08-22 3 sites Stand-alone
    Other conditions: Eosinophilic Esophagitis
    View official trial listing →
  • Terminated NCT NCT03082014

    Effects of Amlodipine and Other Blood Pressure Lowering Agents on Microvascular Function

    Not yet reported Ludwig-Maximilians - University of Munich 101 participants Est. completion 2022-07-28 5 sites
    Other conditions: Cerebral Small Vessel Diseases
    View official trial listing →
  • Status unknown NCT NCT03147092

    Matão Controlling Hypertension (MatCH Study): Rationale and Design

    Not yet reported Centro Neurológico de Pesquisa e Reabiitação, Brazil 15000 participants Est. completion 2021-06-30 Stand-alone
    Other conditions: Hypertension, Blood Pressure
    View official trial listing →
  • Terminated NCT NCT03206788

    Losartan and Inflammation in Cystic Fibrosis

    Not yet reported University of Miami 7 participants Est. completion 2019-12-30 4 sites Stand-alone
    Other conditions: Cystic Fibrosis
    View official trial listing →
  • Completed NCT NCT03217825

    Antihypertensive Effect of Different Doses of Rostafuroxin in Comparison With Losartan

    Not yet reported Windtree Therapeutics 240 participants Est. completion 2018-02-08 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT03276598

    A Study on Molecular Genetics of Drug Responsiveness in Essential Hypertension

    Not yet reported Helsinki University Central Hospital 233 participants Est. completion 2004-04-01 1 site
    Other conditions: Hypertension, Pharmacogenetics
    View official trial listing →
  • Completed NCT NCT03295734

    ACES - ACE Inhibitors Combined With Exercise for Seniors With Hypertension

    Not yet reported University of Alabama at Birmingham 223 participants Est. completion 2024-09-19 2 sites
    Other conditions: Hypertension, Aging, Sedentary Lifestyle
    View official trial listing →
  • Completed NCT NCT03335904

    AT1R Blockade and Periodic Breathing During Sleep in Hypoxia

    Not yet reported University of British Columbia 14 participants Est. completion 2019-08-01 1 site Stand-alone
    Other conditions: Sleep Disordered Breathing, Hypoxia, Respiration; Sleep Disorder, Chemoreceptor Apnea
    View official trial listing →
  • Completed NCT NCT03354143

    Hypertension, Intracranial Pulsatility and Brain Amyloid-beta Accumulation in Older Adults (HIPAC Trial)

    Not yet reported University of Texas Southwestern Medical Center 85 participants Est. completion 2024-03-30 1 site Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Status unknown NCT NCT03357653

    Beginning of Effective and Safe Treatment in Immunoglobulin A-1 Nephropathy-1

    Not yet reported Ewha Womans University 174 participants Est. completion 2021-12-31 Stand-alone
    Other conditions: Glomerulonephritis, Immunoglobulin A (IgA)
    View official trial listing →
  • Terminated NCT NCT03371823

    Vascular Dysfunction in Hypertensive Postmenopausal Women

    Not yet reported University of Delaware 8 participants Est. completion 2019-12-31 1 site Stand-alone
    Cardiovascular disease Other conditions: Hypertension
    View official trial listing →
  • Status unknown NCT NCT03396523

    Losartan and Emotion Processing

    Not yet reported University of Electronic Science and Technology of China 70 participants Est. completion 2018-12-31 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Active, not recruiting NCT NCT03417388

    Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD

    Not yet reported Cedars-Sinai Medical Center 2476 participants Est. completion 2026-09-14 81 sites Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT03434054

    The Effect of Losartan on Emotional Processing in Healthy Volunteers

    Not yet reported University of Oxford 30 participants Est. completion 2017-06-30 Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT03435939

    Effect of Losartan in Cystic Fibrosis (CF)-NIH Grant #133240

    Not yet reported University of Kansas Medical Center 13 participants Est. completion 2026-03-31 1 site Stand-alone
    Other conditions: Cystic Fibrosis
    View official trial listing →
  • Completed NCT NCT03459911

    A Bioequivalence Study of Losartan Potassium Tablets (Containing Losartan Potassium 100 mg) in Normal, Healthy, Adults Under Fasting Conditions

    Not yet reported Pharmtechnology LLC 66 participants Est. completion 2018-03-16 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT03461003

    N-of-1 Trials In Children With Hypertension

    Not yet reported The University of Texas Health Science Center, Houston 49 participants Est. completion 2021-05-02 1 site Stand-alone
    Other conditions: Pediatric Hypertension
    View official trial listing →
  • Terminated NCT NCT03467217

    Losartan for the Treatment of Pediatric NAFLD

    Not yet reported National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 83 participants Est. completion 2020-06-30 10 sites
    MASLD
    View official trial listing →
  • Status unknown NCT NCT03502031

    Safety and Efficacy of Two Year of RAAS Alone or in Combination With Spironolactone Therapy

    Not yet reported James A. Tumlin, MD 72 participants Est. completion 2024-10-01 2 sites
    Chronic kidney disease Other conditions: Renal Insufficiency, Chronic
    View official trial listing →
  • Completed NCT NCT03505853

    A Study to Investigate the Interaction Between Givosiran and a 5-probe Drug Cocktail in Patients With Acute Intermittent Porphyria (AIP)

    Not yet reported Alnylam Pharmaceuticals 10 participants Est. completion 2019-01-10 1 site Stand-alone
    Other conditions: Acute Intermittent Porphyria (AIP), Acute Hepatic Porphyria (AHP), Porphyria, Acute Intermittent, Acute Porphyria
    View official trial listing →
  • Status unknown NCT NCT03526042

    Angiotensin-II Receptor Antibodies Blockade With Losartan in Patients With Lupus Nephritis

    Not yet reported Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 40 participants Est. completion 2019-10-31 1 site Stand-alone
    Other conditions: Atherosclerosis, Lupus Nephritis
    View official trial listing →
  • Active, not recruiting NCT NCT03563248

    Losartan and Nivolumab in Combination With FOLFIRINOX and SBRT in Localized Pancreatic Cancer

    Not yet reported Massachusetts General Hospital 168 participants Est. completion 2027-04 10 sites Stand-alone
    Other conditions: Pancreatic Cancer
    View official trial listing →
  • Completed NCT NCT03563287

    Effects of LRYGB on Pharmacokinetics of Nine CYP Probe Drugs

    Not yet reported University of Eastern Finland 13 participants Est. completion 2014-12-10 1 site Stand-alone
    Other conditions: Obesity, Morbid, Bariatric Surgery Candidate
    View official trial listing →
  • Status unknown NCT NCT03578042

    Fixed-Free HTN Trial

    Not yet reported Hotel Dieu de France Hospital 100 participants Est. completion 2019-12-30 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Status unknown NCT NCT03603938

    Bedtime Potassium Losartan on CKD With Nocturnal Hypertension Patients With Nondipping Blood Pressure Pattern

    Not yet reported Fifth Affiliated Hospital, Sun Yat-Sen University 189 participants Est. completion 2023-12-30 1 site Stand-alone
    Chronic kidney disease
    View official trial listing →
  • Status unknown NCT NCT03604003

    The Role of Isolated Nocturnal Hypertension Pattern in Nondialysis CKD

    Not yet reported Fifth Affiliated Hospital, Sun Yat-Sen University 252 participants Est. completion 2023-12-30 Stand-alone
    Chronic kidney disease
    View official trial listing →
  • Status unknown NCT NCT03610217

    Pragmatic Clinical Trials in Scleroderma

    Not yet reported University of West London 400 participants Est. completion 2021-10 1 site Stand-alone
    Other conditions: Scleroderma, Systemic, Sclerosis, Systemic
    View official trial listing →
  • Status unknown NCT NCT03626259

    Losartan/Amlodipine on Hemodynamics Parameters and Arterial Stiffness in Arterial Hypertension

    Not yet reported Centro Universitario de Ciencias de la Salud, Mexico 28 participants Est. completion 2019-06-14 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Status unknown NCT NCT03632213

    Evaluation of Losartan on Cardiovascular Disease in Patients With Mucopolysaccharidoses IV A and VI

    Not yet reported Hospital de Clinicas de Porto Alegre 10 participants Est. completion 2023-08-03 1 site
    Other conditions: Mucopolysaccharidosis IV A, Mucopolysaccharidosis VI, Mucopolysaccharidoses, MPS IV A, MPS VI, MPS - Mucopolysaccharidosis, Morquio A Syndrome, Morquio Syndrome A, Morquio Syndrome
    View official trial listing →
  • Completed NCT NCT03666351

    Study to Evaluate the Effect on Improvement of LVH by the Control of BP in Hypertension Patients With AV Disease

    Not yet reported Hanmi Pharmaceutical Company Limited 128 participants Est. completion 2022-07-25 1 site Stand-alone
    Other conditions: Aortic Stenosis, Aortic Regurgitation, Hypertension, LVM, Left Ventricular Hypertrophy
    View official trial listing →
  • Status unknown NCT NCT03692013

    Nighttime Losartan in Continous Ambulatory Peritoneal Dialysis (NVCAPD)

    Not yet reported Fifth Affiliated Hospital, Sun Yat-Sen University 68 participants Est. completion 2023-12-01 Stand-alone
    Other conditions: Hypertension,Nephropathy
    View official trial listing →
  • Completed NCT NCT03763409

    Losartan and Emotional Memory

    Not yet reported University of Oxford 53 participants Est. completion 2018-09-28 1 site Stand-alone
    Other conditions: Memory, Learning
    View official trial listing →
  • Completed NCT NCT03864042

    Pharmacokinetic Drug-drug Interaction Study of Encorafenib and Binimetinib on Probe Drugs in Patients With BRAF V600-mutant Melanoma or Other Advanced Solid Tumors

    Not yet reported Pfizer 56 participants Est. completion 2023-05-29 29 sites Stand-alone
    Other conditions: Advanced Solid Tumors, Metastatic Melanoma
    View official trial listing →
  • Terminated NCT NCT03878524

    Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial

    Not yet reported OHSU Knight Cancer Institute 2 participants Est. completion 2020-12-10 1 site Stand-alone
    Other conditions: Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Anatomic Stage IV Breast Cancer AJCC v8, Anemia, Ann Arbor Stage III Hodgkin Lymphoma, Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma, Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Castration-Resistant Prostate Carcinoma, Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Hematopoietic and Lymphoid System Neoplasm, Locally Advanced Pancreatic Adenocarcinoma, Metastatic Breast Carcinoma, Metastatic Malignant Solid Neoplasm, Metastatic Pancreatic Adenocarcinoma, Myelodysplastic/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis, Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable, Primary Myelofibrosis, Recurrent Acute Lymphoblastic Leukemia, Recurrent Acute Myeloid Leukemia, Recurrent Chronic Lymphocytic Leukemia, Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Recurrent Hematologic Malignancy, Recurrent Hodgkin Lymphoma, Recurrent Myelodysplastic Syndrome, Recurrent Myelodysplastic/Myeloproliferative Neoplasm, Recurrent Myeloproliferative Neoplasm, Recurrent Non-Hodgkin Lymphoma, Recurrent Plasma Cell Myeloma, Recurrent Small Lymphocytic Lymphoma, Refractory Acute Lymphoblastic Leukemia, Refractory Acute Myeloid Leukemia, Refractory Chronic Lymphocytic Leukemia, Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Refractory Chronic Myelomonocytic Leukemia, Refractory Hematologic Malignancy, Refractory Hodgkin Lymphoma, Refractory Malignant Solid Neoplasm, Refractory Myelodysplastic Syndrome, Refractory Myelodysplastic/Myeloproliferative Neoplasm, Refractory Non-Hodgkin Lymphoma, Refractory Plasma Cell Myeloma, Refractory Primary Myelofibrosis, Refractory Small Lymphocytic Lymphoma, Stage II Pancreatic Cancer AJCC v8, Stage III Pancreatic Cancer AJCC v8, Stage IV Pancreatic Cancer AJCC v8, Stage IV Prostate Cancer AJCC v8, Unresectable Pancreatic Adenocarcinoma
    View official trial listing →
  • Completed NCT NCT03897868

    A Phase 2 Study to Assess Dose-response Relationship of HCP1803 in Patients With Essential Hypertension

    Not yet reported Hanmi Pharmaceutical Company Limited 248 participants Est. completion 2020-02-26 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT03912285

    The Pharmacokinetic Interaction Between Amlodipine and Losartan

    Not yet reported Korea University Anam Hospital 24 participants Est. completion 2009-06-09 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT03946514

    Efficacy and Safety of a Single-pill Fixed Combination of Sufficient Losartan/Hydrochlorothiazide in Chinese Hypertensive Patients

    Not yet reported Shanghai Jiao Tong University School of Medicine 180 participants Est. completion 2024-08-31 1 site Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Status unknown NCT NCT03951142

    Imaging Perfusion Restrictions From Extracellular Solid Stress - An Open-label Losartan Study

    Not yet reported Kyrre Eeg Emblem 165 participants Est. completion 2024-12-31 1 site Stand-alone
    Other conditions: Glioblastoma, Brain Metastases
    View official trial listing →
  • Status unknown NCT NCT03953950

    Effect of Add-on Spironolactone to Losartan Versus Losartan Alone on Peritoneal Membrane Among Peritoneal Dialysis Patients

    Not yet reported Chiang Mai University 84 participants Est. completion 2020-12 1 site Stand-alone
    Other conditions: End Stage Renal Disease, Peritoneal Dialysis
    View official trial listing →
  • Withdrawn NCT NCT03978884

    Phase 4 Study of the Efficacy of Losartan Based Therapy in Hypertensives With and Without Diabetes

    Not yet reported The University of The West Indies Est. completion 2020-12-31 1 site Stand-alone
    Other conditions: Diabetes Mellitus, Hypertension
    View official trial listing →
  • Completed NCT NCT04049734

    Oral Losartan in Prevention of Post-ERCP Paancreatitis

    Not yet reported Ain Shams University 100 participants Est. completion 2017-03
    Other conditions: Post-ERCP Acute Pancreatitis
    View official trial listing →
  • Completed NCT NCT04061824

    Clinical Study to Evaluate Adherence Improvement Fixed-dose Combination of Olostar Tab. in Patients With Hypertension and Dyslipidemia

    Not yet reported Yonsei University 150 participants Est. completion 2018-12-20 1 site
    Other conditions: Hypertension, Dyslipidemias
    View official trial listing →
  • Completed NCT NCT04074551

    A Phase 3 Study to Compare the Efficacy and Safety of Co-administered HGP0608, HGP0904 and HCP1306 Versus HCP1701 in Patients With Hypertension and Dyslipidemia

    Not yet reported Hanmi Pharmaceutical Company Limited 145 participants Est. completion 2020-03-17 1 site
    Other conditions: Hypertension, Dyslipidemias
    View official trial listing →
  • Status unknown NCT NCT04078711

    Chinese Medicine Treat for Hypertensive Renal Injury

    Not yet reported, Not yet reported Jiangsu Province Hospital of Traditional Chinese Medicine 520 participants Est. completion 2021-12-30 Stand-alone
    Other conditions: Hypertension, Renal Injury
    View official trial listing →
  • Completed NCT NCT04081844

    A Study to Evaluate the Pharmacokinetic and Pharmacodynamic Interactions Between HGP0904, HGP0608, and HCP1306 in Healthy Male Subjects.

    Not yet reported Hanmi Pharmaceutical Company Limited 31 participants Est. completion 2018-06-28 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT04106856

    Losartan and Hypofractionated Rx After Chemo for Tx of Borderline Resectable or Locally Advanced Pancreatic Cancer

    Not yet reported University of Utah 22 participants Est. completion 2026-02-17 1 site Stand-alone
    Other conditions: Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Ductal Adenocarcinoma, Locally Advanced Unresectable Pancreatic Adenocarcinoma, Stage II Pancreatic Cancer AJCC v8, Stage IIA Pancreatic Cancer AJCC v8, Stage IIB Pancreatic Cancer AJCC v8, Stage III Pancreatic Cancer AJCC v8
    View official trial listing →
  • Completed NCT NCT04158154

    Transforming Hypertension Treatment in Nigeria Using a Type II Hybrid, Interrupted Time Series Design

    Not yet reported Washington University School of Medicine 21922 participants Est. completion 2023-12-31 60 sites Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT04201197

    Interactions Between Cannabinoids and Cytochrome P450-Metabolized Drugs

    Not yet reported Johns Hopkins University 22 participants Est. completion 2022-07-28 1 site
    Other conditions: Drug-Interactions
    View official trial listing →
  • Terminated NCT NCT04212650

    Losartan to Improve Hip Microfracture

    Not yet reported, Not yet reported Steadman Philippon Research Institute 1 participants Est. completion 2020-12-04 1 site Stand-alone
    Osteoarthritis Other conditions: Hip Impingement Syndrome, Cartilage Damage, Fibrosis
    View official trial listing →
  • Completed NCT NCT04222686

    Evaluation of Losartan and Perindopril in Blacks Type 2 Diabetics Patients

    Not yet reported Yaounde Central Hospital 23 participants Est. completion 2018-04-30 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT04238702

    Renohemodynamic Effects of Combined empagliflOzin and LosARtan

    Not yet reported Amsterdam UMC, location VUmc 24 participants Est. completion 2021-09-27 1 site Stand-alone
    Type 2 diabetesChronic kidney disease
    View official trial listing →
  • Completed NCT NCT04278495

    The Effect of Losartan on the Recoverability of Renal Function in Anuric and Oliguric Patients With Unilateral Obstructed Kidney

    Not yet reported Mansoura University 96 participants Est. completion 2018-12-01 1 site
    Obstructive sleep apnea Other conditions: Uropathy, Uropathy Obstructive
    View official trial listing →
  • Completed NCT NCT04311177

    Losartan for Patients With COVID-19 Not Requiring Hospitalization

    Not yet reported University of Minnesota 117 participants Est. completion 2021-02-01 4 sites Stand-alone
    Other conditions: Corona Virus Infection, Acute Respiratory Distress Syndrome, SARS-CoV Infection
    View official trial listing →
  • Completed NCT NCT04312009

    Losartan for Patients With COVID-19 Requiring Hospitalization

    Not yet reported University of Minnesota 205 participants Est. completion 2021-02-01 13 sites Stand-alone
    Other conditions: Corona Virus Infection, Acute Respiratory Distress Syndrome, SARS-CoV Infection
    View official trial listing →
  • Completed NCT NCT04322266

    A Study to Compare the Pharmacokinetics, Safety and Tolerability Between Fixed-Dose Combination and Co-Administration of HGP0904, HGP0608 and HCP1306 Tablets in Healthy Male Subjects.

    Not yet reported Hanmi Pharmaceutical Company Limited 61 participants Est. completion 2019-02-13 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Terminated NCT NCT04328012

    COVID MED Trial - Comparison Of Therapeutics for Hospitalized Patients Infected With COVID-19

    Not yet reported, Not yet reported Bassett Healthcare 15 participants Est. completion 2021-12-01 1 site Stand-alone
    Other conditions: SARS-CoV-2 Infection
    View official trial listing →
  • Suspended NCT NCT04330300

    Coronavirus (COVID-19) ACEi/ARB Investigation

    Not yet reported National University of Ireland, Galway, Ireland 2414 participants Est. completion 2021-12-01 1 site
    Other conditions: Hypertension, COVID-19
    View official trial listing →
  • Completed NCT NCT04335123

    Study of Open Label Losartan in COVID-19

    Not yet reported University of Kansas Medical Center 34 participants Est. completion 2020-08-17 1 site Stand-alone
    Other conditions: COVID-19
    View official trial listing →
  • Completed NCT NCT04340557

    Do Angiotensin Receptor Blockers Mitigate Progression to Acute Respiratory Distress Syndrome With SARS-CoV-2 Infection

    Not yet reported Sharp HealthCare 31 participants Est. completion 2020-06-13 3 sites Stand-alone
    Other conditions: SARS-CoV Infection
    View official trial listing →
  • Withdrawn NCT NCT04343001

    Coronavirus Response - Active Support for Hospitalised Covid-19 Patients

    Not yet reported London School of Hygiene and Tropical Medicine Est. completion 2021-08 2 sites Stand-alone
    Other conditions: Covid-19
    View official trial listing →
  • Completed NCT NCT04349410

    The Fleming [FMTVDM] Directed CoVid-19 Treatment Protocol

    Not yet reported, Not yet reported The Camelot Foundation 1800 participants Est. completion 2020-09-14 1 site Stand-alone
    Other conditions: CoVid 19 Positive
    View official trial listing →
  • Completed NCT NCT04394117

    Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY Disease

    Not yet reported The George Institute 787 participants Est. completion 2022-01-17 22 sites
    Other conditions: Coronavirus Disease 2019, COVID-19
    View official trial listing →
  • Withdrawn NCT NCT04428268

    Chloroquine + Losartan Compared to Chloroquine Alone for the Treatment of COVID-19 Pneumonia

    Not yet reported Hospital Universitario Dr. Jose E. Gonzalez Est. completion 2021-02-16 1 site Stand-alone
    Other conditions: COVID-19 Pneumonia
    View official trial listing →
  • Terminated NCT NCT04447235

    Early Treatment With Ivermectin and LosarTAN for Cancer Patients With COVID-19 Infection

    Not yet reported Instituto do Cancer do Estado de São Paulo 77 participants Est. completion 2022-06-30 1 site Stand-alone
    Other conditions: Cancer, COVID, Coronavirus Infection
    View official trial listing →
  • Completed NCT NCT04467931

    ACEI or ARB and COVID-19 Severity and Mortality in US Veterans

    University of Utah 22213 participants Est. completion 2020-12-31 1 site
    Other conditions: Hypertension, COVID
    View official trial listing →
  • Terminated NCT NCT04504045

    Metformin's Effect on Drug Metabolism in Patients With Type 2 Diabetes

    Not yet reported University of Southern Denmark 10 participants Est. completion 2022-05-10 1 site Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Active, not recruiting NCT NCT04539808

    NeoOPTIMIZE: Early Switching of mFOLFIRINOX or Gemcitabine/Nab-Paclitaxel Before Surgery for the Treatment of Resectable, Borderline Resectable, or Locally-Advanced Unresectable Pancreatic Cancer

    Not yet reported OHSU Knight Cancer Institute 42 participants Est. completion 2027-01-05 1 site Stand-alone
    Other conditions: Pancreatic Adenocarcinoma, Stage 0 Pancreatic Cancer American Joint Committee on Cancer v8, Stage I Pancreatic Cancer American Joint Committee on Cancer v8, Stage III Pancreatic Cancer American Joint Committee on Cancer v8, Stage IV Pancreatic Cancer American Joint Committee on Cancer v8
    View official trial listing →
  • Completed NCT NCT04591210

    The COVID-RASi Trial (COVID-19)

    Not yet reported Ottawa Heart Institute Research Corporation 372 participants Est. completion 2024-12-30 31 sites Stand-alone
    Cardiovascular disease Other conditions: COVID-19
    View official trial listing →
  • Status unknown NCT NCT04604756

    The Effects of Losartan on Social Reward

    Not yet reported University of Electronic Science and Technology of China 90 participants Est. completion 2022-03-31 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT04604938

    The Effects of Losartan on Reward Reinforcement Learning

    Not yet reported University of Electronic Science and Technology of China 60 participants Est. completion 2022-03-31 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT04606212

    The Effects of Losartan on Emotion Processing

    Not yet reported University of Electronic Science and Technology of China 90 participants Est. completion 2022-03-31 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT04606225

    Losartan Effects on Emotion-memory Interaction

    Not yet reported University of Electronic Science and Technology of China 60 participants Est. completion 2022-03-31 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Terminated NCT NCT04606563

    Host Response Mediators in Coronavirus (COVID-19) Infection - Is There a Protective Effect of Losartan and Other ARBs on Outcomes of Coronavirus Infection?

    Not yet reported University of British Columbia 341 participants Est. completion 2022-04-22 13 sites Stand-alone
    Other conditions: Covid19, SARS-CoV Infection
    View official trial listing →
  • Completed NCT NCT04632589

    Losartan for Improved Vascular Endothelial Function After Preeclampsia

    Not yet reported Anna Stanhewicz, PhD 11 participants Est. completion 2025-03-13 1 site Stand-alone
    Other conditions: Preeclampsia Postpartum
    View official trial listing →
  • Terminated NCT NCT04643691

    Losartan and Spironolactone Treatment for ICU Patients With COVID-19 Suffering From ARDS

    Not yet reported Assistance Publique Hopitaux De Marseille 78 participants Est. completion 2021-12-07 1 site Stand-alone
    Other conditions: COVID-19, ARDS
    View official trial listing →
  • Status unknown NCT NCT04743063

    Prospective Monitoring of Angiotensin Receptor Neprilysin Inhibitor in Older Adults With Heart Failure and Frailty

    Brigham and Women's Hospital 40000 participants Est. completion 2022-12-31 1 site
    Heart failure Other conditions: Frailty
    View official trial listing →
  • Status unknown NCT NCT04815902

    Use of Senolytic and Anti-Fibrotic Agents to Improve the Beneficial Effect of Bone Marrow Stem Cells for Osteoarthritis

    Not yet reported, Not yet reported Steadman Philippon Research Institute 100 participants Est. completion 2025-06-01 1 site Stand-alone
    Osteoarthritis
    View official trial listing →
  • Completed NCT NCT04820907

    Clinical Efficacy and Safety Evaluation of HCP1904-1 in Essential Hypertension Patients

    Not yet reported Hanmi Pharmaceutical Company Limited 123 participants Est. completion 2021-09-30 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT04830449

    Clinical Efficacy and Safety Evaluation of HCP1904-2 in Essential Hypertension Patients

    Not yet reported Hanmi Pharmaceutical Company Limited 122 participants Est. completion 2021-08-24 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT04840641

    Flucloxacillin as an Inducer of CYP-enzymes

    Not yet reported University of Southern Denmark 14 participants Est. completion 2021-12-28 1 site
    Other conditions: Healthy Volunteers, Drug Drug Interaction
    View official trial listing →
  • Completed NCT NCT04927299

    Efficacy and Safety of Losartan/Chlorthalidone vs Losartan/Hydrochlorothiazide in Essential Arterial Hypertension

    Not yet reported Laboratorios Silanes S.A. de C.V. 163 participants Est. completion 2023-09-11 1 site Stand-alone
    Other conditions: Essential Arterial Hypertension
    View official trial listing →
  • Completed NCT NCT04954560

    Effect of Losartan or Eprosartan on Fructose Hyperuricemia

    Not yet reported Medical University of Lodz 16 participants Est. completion 2010-01-01
    Other conditions: Uric Acid Concentration, Serum, Quantitative Trait Locus 7
    View official trial listing →
  • Completed NCT NCT05012631

    Losartan for Diffuse Myocardial Fibrosis in Sickle Cell Disease

    Not yet reported Children's Hospital Medical Center, Cincinnati 14 participants Est. completion 2026-05-28 1 site Stand-alone
    Other conditions: Sickle Cell Disease, Diffuse Myocardial Fibrosis
    View official trial listing →
  • Status unknown NCT NCT05025956

    Senolytic Agent Improve the Benefit of Platelet-Rich Plasma and Losartan

    Not yet reported, Not yet reported Steadman Philippon Research Institute 68 participants Est. completion 2024-10-31 1 site
    Other conditions: Femoroacetabular Impingement
    View official trial listing →
  • Status unknown NCT NCT05064904

    Multidiscipline Care for Acute Kidney Disease (AKD)

    Not yet reported National Taiwan University Hospital 300 participants Est. completion 2024-02-15 7 sites
    Other conditions: Acute Kidney Injury
    View official trial listing →
  • Active, not recruiting NCT NCT05077800

    FOLFIRINOX + Elraglusib + Losartan In Pancreatic Cancer

    Not yet reported Colin D. Weekes, M.D., PhD 70 participants Est. completion 2026-12-31 4 sites Stand-alone
    Other conditions: Pancreatic Adenocarcinoma, Pancreatic Adenocarcinoma Metastatic
    View official trial listing →
  • Completed NCT NCT05090449

    Non-interaction Study of Chlorthalidone and Losartan in Fixed Combination, in Healthy Subjects, Under Fasting Conditions

    Not yet reported Laboratorios Silanes S.A. de C.V. 36 participants Est. completion 2020-05-25 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT05097248

    Camrelizumab in Combination With PLD and Losartan in Patients With TNBC Who Have Received ≦ 1 Line of Chemotherapy

    Not yet reported Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 52 participants Est. completion 2024-10 1 site Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT05132712

    Effects of Angiotensin Converting Enzyme Inhibitors on Patency of Arterio-Venous Fistulas: A Randomized Controlled Trial

    Not yet reported Armed Forces Post Graduate Medical Institute (AFPGMI), Rawalpindi 100 participants Est. completion 2022-09-30 1 site Stand-alone
    Other conditions: Vascular Access Complication
    View official trial listing →
  • Withdrawn NCT NCT05157464

    Losartan Use to Mitigate Arthrofibrosis Following Total Join Arthroplasty

    Not yet reported NYU Langone Health Est. completion 2024-12-31 1 site Stand-alone
    Other conditions: Arthrofibrosis
    View official trial listing →
  • Completed NCT NCT05199129

    Clinical Efficacy and Safety Evaluation of HCP1904-3 in Essential Hypertension Patients

    Not yet reported Hanmi Pharmaceutical Company Limited 166 participants Est. completion 2022-09-14 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Status unknown NCT NCT05212597

    Open Label RCT for Chronic Severe AR : Entresto vs. CCB/ARB

    Not yet reported Samsung Medical Center 100 participants Est. completion 2024-12 1 site
    Other conditions: Aortic Valve Insufficiency
    View official trial listing →
  • Completed NCT NCT05232370

    The Effect of Enalapril, Losartan or Not Antihypertensive on the Oxidative Status in Renal Transplant Recipients

    Not yet reported Unidad de Investigacion Medica en Enfermedades Renales 39 participants Est. completion 2022-01-06 1 site Stand-alone
    Other conditions: Oxidative Stress
    View official trial listing →
  • Status unknown NCT NCT05243446

    Cardiorenal Effecs of Losartan in Kidney Transplant Recipients

    Medical University of Gdansk 740 participants Est. completion 2023-12-31 1 site
    Other conditions: Renal Transplant Failure, Cardiovascular Complication
    View official trial listing →
  • Status unknown NCT NCT05271448

    Continuing or Discontinuing ACE/ARBs in Patients With Chronic Kidney Disease Undergoing Coronary Angiography

    Not yet reported An-Najah National University 600 participants Est. completion 2024-08-01 1 site Stand-alone
    Chronic kidney disease Other conditions: Contrast-induced Nephropathy, Ischemic Heart Disease
    View official trial listing →
  • Active, not recruiting NCT NCT05331144

    Impact of Intensive Treatment of SBP on Brain Perfusion, Amyloid, and Tau (IPAT Study)

    Not yet reported Rong Zhang 180 participants Est. completion 2028-08-31 1 site Stand-alone
    Other conditions: Cognitively Normal Older Adults, Hypertension, Subjective Cognitive Decline, Family History of Dementia
    View official trial listing →
  • Completed NCT NCT05349825

    Investigation of MDR1 Gene Polymorphism and Losartan Plasma Concentration in Patients Undergoing Hypertensive Episodes While Under Losartan Treatment

    Pamukkale University 100 participants Est. completion 2019-01-15 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Active, not recruiting NCT NCT05365893

    PHL Treatment in Pancreatic Cancer

    Not yet reported Fox Chase Cancer Center 20 participants Est. completion 2026-12-31 1 site Stand-alone
    Other conditions: Pancreatic Ductal Adenocarcinoma
    View official trial listing →
  • Terminated NCT NCT05370599

    Hypertension in Young Adults Trial

    Not yet reported University of California, San Francisco 36 participants Est. completion 2026-01-07 1 site Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT05402397

    Losartan and Uric Acid Metabolism in Children With Proteinuric Nephropathies

    Not yet reported Hospital General de Niños Pedro de Elizalde 40 participants Est. completion 2024-01-01 1 site Stand-alone
    Other conditions: Uric Acid Nephropathy
    View official trial listing →
  • Completed NCT NCT05450575

    An Observational Study to Evaluate Effectiveness and Safety of Amosartan Q Tablet

    Hanmi Pharmaceutical Company Limited 5400 participants Est. completion 2021-07-20 1 site
    Other conditions: Hypertension, Dyslipidemia
    View official trial listing →
  • Completed NCT NCT05462535

    An Observational Study to Evaluate Effectiveness and Safety of Amosartan Plus Tablet

    Hanmi Pharmaceutical Company Limited 4785 participants Est. completion 2021-07-15 1 site
    Other conditions: Hypertension,Essential
    View official trial listing →
  • Completed NCT NCT05479097

    Feasibility Study of a Novel mHealth Application to Enable Community Health Workers to Manage

    Not yet reported University of Wisconsin, Madison 32 participants Est. completion 2023-12-31 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT05576155

    Sex Differences in the Dilatory Response of Compound 21

    Not yet reported Anna Stanhewicz, PhD 26 participants Est. completion 2023-02-23 1 site Stand-alone
    Other conditions: Sex Differences
    View official trial listing →
  • Completed NCT NCT05607017

    Losartan in Prevention of Radiation-Induced Heart Failure

    Not yet reported Massachusetts General Hospital 5 participants Est. completion 2025-10-07 1 site Stand-alone
    Other conditions: Breast Cancer, Myocardial Fibrosis, Radiation-Induced Fibrosis
    View official trial listing →
  • Active, not recruiting NCT NCT05619653

    Myocardial Protection in Patients With Post-acute Inflammatory Cardiac Involvement Due to COVID-19

    Not yet reported Valentina Puentmann 279 participants Est. completion 2026-03-31 5 sites
    Other conditions: COVID-19 Associated Cardiac Involvement, Remodeling, Left Ventricle, Remodeling, Vascular, Left Ventricular Dysfunction, Exercise Intolerance, Vascular Inflammation, Microvascular Angina, Long COVID, Myocarditis, Pericarditis
    View official trial listing →
  • Completed NCT NCT05631782

    Effects of Shenkang Decoction on Creatinine and Blood Urea Nitrogen in Chronic Renal Failure Hemodialysis Patients

    Not yet reported The First People's Hospital of Zunyi 160 participants Est. completion 2021-12-26 1 site
    Other conditions: Chronic Renal Failure, Hemodialysis
    View official trial listing →
  • Active, not recruiting NCT NCT05637216

    Losartan to Reduce Radiation Induced Fibrosis in Breast Cancer Patients

    Not yet reported Shaw Cancer Center 43 participants Est. completion 2027-08-17 1 site Stand-alone
    Other conditions: Radiation Induced Fibrosis
    View official trial listing →
  • Active, not recruiting NCT NCT05637853

    Telemonitored Fast Track Medical Sequencing for Heart Failure With Reduced Ejection Fraction

    Not yet reported Göteborg University 60 participants Est. completion 2026-08-26 1 site Stand-alone
    Heart failure
    View official trial listing →
  • Completed NCT NCT05713396

    Diabetic Autonomic Neuropathy and Left Ventricular Function

    Not yet reported AHEPA University Hospital 59 participants Est. completion 2022-06-01 1 site Stand-alone
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Status unknown NCT NCT05753696

    Azilsartan in Patients With Diabetic Kidney Disease and Hypertension

    Not yet reported Second Affiliated Hospital, Zhejiang University, School of Medicine 106 participants Est. completion 2024-12-30 1 site
    Chronic kidney disease Other conditions: Proteinuria, Kidney Dysfunction, Blood Pressure
    View official trial listing →
  • Completed NCT NCT05827484

    The Effect of Combined Use of Anti-fibrotic Agent With Platelet Rich Plasma on Skeletal Muscle Healing After Acute Injuries

    Not yet reported Mostafa Hassanein, Msc 20 participants Est. completion 2017-12-12 Stand-alone
    Obstructive sleep apnea Other conditions: PRP, Muscle Injury, Sport Injury
    View official trial listing →
  • Completed NCT NCT05828940

    Losartan and Memory

    Not yet reported University of Oxford 41 participants Est. completion 2022-03-31 1 site Stand-alone
    Other conditions: PTSD
    View official trial listing →
  • Status unknown NCT NCT05843162

    A Clinical Trial to Evaluate the Blood Pressure Control of Telmisartan or Losartan in Essential Hypertensive Patients With Metabolic Syndrome

    Not yet reported Chong Kun Dang Pharmaceutical 116 participants Est. completion 2023-12-31
    Metabolic syndrome Other conditions: Essential Hypertension
    View official trial listing →
  • Withdrawn NCT NCT05861336

    GEM+Nab-Paclitaxel Plus Losartan Followed by Stereotactic Radiotherapy for Locally Advanced Pancreatic Cancer

    Not yet reported Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS Est. completion 2024-12-23 2 sites Stand-alone
    Other conditions: Pancreatic Cancer
    View official trial listing →
  • Status unknown NCT NCT05871333

    Effect of Losartan on the Incidence and Severity of Chemotherapy-Induced Mucositis in Gastrointestinal Cancer Patients

    Not yet reported Ain Shams University 80 participants Est. completion 2024-07-01 1 site Stand-alone
    Other conditions: Chemotherapy, Colorectal Cancer, Intestinal Mucositis, Oral Mucositis
    View official trial listing →
  • Status unknown NCT NCT05893108

    Ethosomal Gel Bearing Losartan 5% for Keloid Treatment

    Not yet reported, Not yet reported Yuni Eka Anggraini 46 participants Est. completion 2024-10-30 1 site Stand-alone
    Other conditions: Keloid
    View official trial listing →
  • Status unknown NCT NCT05954884

    Community-based HEARTS Intervention (Pilot)

    Not yet reported National Heart Foundation of Bangladesh 400 participants Est. completion 2025-03-31 Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT06135493

    Prevention of Paclitaxel-induced Peripheral Neuropathy in Breast Cancer Patients

    Not yet reported Future University in Egypt 84 participants Est. completion 2025-03-30 1 site Stand-alone
    Other conditions: Peripheral Neuropathy Due to Chemotherapy
    View official trial listing →
  • Status unknown NCT NCT06329050

    The Effects of Losartan on Attention Control: An Eye-tracking Study

    Not yet reported University of Electronic Science and Technology of China 80 participants Est. completion 2025-07-30 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT06329076

    Losartan Modulates Neural Responses to Looming Visual Stimuli: An Eye-tracking Study

    Not yet reported University of Electronic Science and Technology of China 80 participants Est. completion 2025-07-30 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Withdrawn NCT NCT06333522

    Losartan Use to Mitigate Arthrofibrosis Following Total Joint Arthroplasty

    Not yet reported NYU Langone Health Est. completion 2026-01-01 1 site Stand-alone
    Other conditions: Arthrofibrosis of Knee
    View official trial listing →
  • Status unknown NCT NCT06344247

    Comparison of the Efficacy and Safety of SGLT2i and GLP-1 Receptor Agonists in Obese Patients With Kidney Disease

    Not yet reported RenJi Hospital 48 participants Est. completion 2025-12-01 1 site Stand-alone
    Chronic kidney disease Other conditions: Obesity
    View official trial listing →
  • Status unknown NCT NCT06366386

    Integrating Hypertension Management in DSD for HIV

    Infectious Diseases Research Collaboration, Uganda 1100 participants Est. completion 2026-05-30 1 site
    Other conditions: Hypertension, HIV
    View official trial listing →
  • Status unknown NCT NCT06431477

    Efficacy and Safety of Telmisartan Compared With Losartan

    Not yet reported Chong Kun Dang Pharmaceutical 98 participants Est. completion 2025-10-31 1 site
    Other conditions: Diabetic Nephropathies, Hypertension
    View official trial listing →
  • Status unknown NCT NCT06491940

    Comparison of the Role of Losartan Alone vs Hydrochlorothiazide Plus Losartan

    Not yet reported RESnTEC, Institute of Research 234 participants Est. completion 2025-07-31 1 site Stand-alone
    Other conditions: Proteinuria
    View official trial listing →
  • Status unknown NCT NCT06515678

    Impact of Antihypertensive Therapy on Recurrence Risk of Ovarian Cancer for Bevacizumab-associated Hypertension

    Groupe Hospitalier Pitie-Salpetriere 9464 participants Est. completion 2024-08-31 2 sites
    Other conditions: Ovarian Cancer, Antiangiogenic-Associated Hypertension, Adjuvant Bevacizumab, Hypertension
    View official trial listing →
  • Status unknown NCT NCT06539806

    Clinical Study Evaluating the Effect of Losartan

    Not yet reported Tanta University 90 participants Est. completion 2026-08-20 1 site
    Other conditions: Pancreatic Cancer
    View official trial listing →
  • Completed NCT NCT06718062

    Non-Inferiority Study of Aliskiren vs Losartan in the Treatment of Hypertension With Hyperuricemia

    Not yet reported Hansung University 66 participants Est. completion 2024-10-01 1 site
    Other conditions: Hypertension,Essential, Hyperuricemia
    View official trial listing →
  • Not yet recruiting NCT NCT06796660

    Exploring the Impact of Nephropathy Formula No. 1 on Chronic Kidney Disease Patients

    Not yet reported Liu Zhanghong 70 participants Est. completion 2027-12-31 3 sites Stand-alone
    Other conditions: Renal Insufficiency, Chronic
    View official trial listing →
  • Completed NCT NCT06831864

    Heart Failure With Reduced Ejection Fraction Polypill Implementation Strategy in Sri Lanka

    Not yet reported Washington University School of Medicine 40 participants Est. completion 2025-05-05 2 sites Stand-alone
    Heart failure
    View official trial listing →
  • Completed NCT NCT06930872

    Drug Interaction Study of ZYN002 Transdermal Gel and Probe Substrates

    Not yet reported Harmony Biosciences Management, Inc. 29 participants Est. completion 2025-11-04 1 site Stand-alone
    Other conditions: Drug Interaction
    View official trial listing →
  • Not yet recruiting NCT NCT07135687

    Study to Use Oral Losartan to Decrease the Risk of Postoperative Scarring Following (ACL) Reconstruction

    Not yet reported Rush University Medical Center 144 participants Est. completion 2028-12 1 site Stand-alone
    Other conditions: ACL Injury, ACL Reconstruction, Scar Formation
    View official trial listing →
  • Not yet recruiting NCT NCT07160361

    Exploration of Postoperative Adjuvant Therapy for HCC Patients With Positive TB

    Not yet reported Second Affiliated Hospital of Xi'an Jiaotong University 56 participants Est. completion 2029-12-31 Stand-alone
    Other conditions: Carcinoma, Hepatocellular
    View official trial listing →
  • Not yet recruiting NCT NCT07262710

    Association of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers With Post-Stroke Pneumonia: A Real-World Retrospective Cohort Study

    First Teaching Hospital of Tianjin University of Traditional Chinese Medicine 13656 participants Est. completion 2026-08-19
    Cardiovascular disease
    View official trial listing →
  • Not yet recruiting NCT NCT07265739

    Losartan and Paclitaxel in Platinum Resistant Ovarian Cancer

    Not yet reported Massachusetts General Hospital 27 participants Est. completion 2028-12-30 1 site Stand-alone
    Other conditions: Platinum Resistant Ovarian Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07547878

    Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD)

    Not yet reported Baylor Research Institute 64 participants Est. completion 2029-03-31 1 site
    Chronic kidney diseaseType 2 diabetes
    View official trial listing →
  • Enrolling by invitation NCT NCT07568574

    Impact of Medically Supervised Performance-Enhancing Substances (PES) on Elite Athletes

    Not yet reported Enhanced Emirates Limited 60 participants Est. completion 2033-03-01 1 site Stand-alone
    Other conditions: Safety and Impact of Medically Supervised Performance Enhancing Substance Usage in Healthy Elite Athletes
    View official trial listing →
  • Active, not recruiting NCT NCT07586371

    Proteinuria in Normotensive Diabetic Patients: ARBs Alone or in Combination of SGLT2i

    Not yet reported, Not yet reported Dr Mudassar Saeed Pansota 60 participants Est. completion 2026-08-05 1 site Stand-alone
    Other conditions: Proteinuria, Diabetes (DM)
    View official trial listing →
  • Not yet recruiting NCT NCT07735130

    Angiotensin Receptor Blocker After TAVR in Severe Aortic Stenosis With Left Ventricular Hypertrophy (ARBITAR)

    Not yet reported Seoul National University Hospital 632 participants Est. completion 2030-06-15 1 site Stand-alone
    Other conditions: Transcatheter Aortic Valve Replacement (TAVR), Left Ventricular Hypertrophy, Severe Aortic Stenosis
    View official trial listing →
  • Not yet recruiting NCT NCT07748273

    Rosuvastatin and Losartan Pharmacokinetics After Bariatric Surgery

    Not yet reported Hospital das Clínicas de Ribeirão Preto 60 participants Est. completion 2027-05-15 1 site Stand-alone
    Other conditions: Obesity & Overweight, Bariatric Surgery, Pharmacokinetics After Oral Intake, Drug Absorption
    View official trial listing →
  • Not yet recruiting NCT NCT07762703

    Combination Immunotherapy Treatment for Locally Advanced Unresectable or Metastatic, PD-L1 Negative (CPS<10), gBRCA Negative, Triple Negative Breast Cancer Including BreakVax ImmunoTreatment (Designed and Manufactured Per Patient), Chemotherapy and Anti PD-1 Therapy

    Not yet reported, Not yet reported BreakBio Corp 10 participants Est. completion 2030-09 1 site Stand-alone
    Other conditions: Triple-Negative Breast Cancer (TNBC)
    View official trial listing →
  • Not yet recruiting NCT NCT07762716

    Combination Immunotherapy Treatment for Glioblastoma Including BreakVax ImmunoTreatment (Designed and Manufactured Per Patient), Chemotherapy and Anti PD-1 Therapy

    Not yet reported, Not yet reported BreakBio Corp 10 participants Est. completion 2030-09 1 site Stand-alone
    Other conditions: Glioblastoma (GBM)
    View official trial listing →
  • Not yet recruiting NCT NCT07784621

    A Phase 1 Clinical Trial to Evaluate the Safety and the Pharmacokinetic Drug-Drug Interaction Between HUC2A-752-A and HUC2A-752-B in Healthy Adults

    Not yet reported Huons Co., Ltd. 30 participants Est. completion 2027-02 1 site Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT07823140

    Effects of Kudzu Root (Gegen) on Drug-Metabolizing Enzymes and Blood Clotting in Healthy Volunteers

    Not yet reported Chinese University of Hong Kong 56 participants Est. completion 2023-04-28 1 site Stand-alone
    Other conditions: Herb-drug Interactions
    View official trial listing →
  • Not yet recruiting NCT NCT07828002

    The GranStone Trial

    Not yet reported, Not yet reported Martin Blomberg Jensen 100 participants Est. completion 2029-04 1 site
    Other conditions: Paraffinoma, Granuloma, Foreign-Body
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources

Also known as: Losartan Potassium, Losartan Potassium and Hydrochlorothiazide, Losartan potassium Tablets, 100 mg, Losartan, Losartan 100 mg

Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.